Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
[Display omitted] •Progress of preclinical and clinical research into engineered nanomedicine is helping to bring new effective diagnostic and therapeutic approaches to cancer patients.•Biomarker-driven engineered nanoparticles offer enhanced cancer-specific and personalized therapy.•Engineered nano...
Saved in:
| Published in | Advanced drug delivery reviews Vol. 189; p. 114482 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.10.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | [Display omitted]
•Progress of preclinical and clinical research into engineered nanomedicine is helping to bring new effective diagnostic and therapeutic approaches to cancer patients.•Biomarker-driven engineered nanoparticles offer enhanced cancer-specific and personalized therapy.•Engineered nanoparticles represent an efficient tool to deliver different types of treatments for patients with difficult-to-treat cancers.•Surface-engineered nanoparticles have the potential to overcome the physical and biological barriers that are known to limit the effectiveness of unmodified or unfunctionalized nanoparticles.
Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However, nanoparticles are still subject to biological barriers and biodistribution challenges, which limit their overall clinical potential. This has motivated the implementation of innovational modifications to a range of nanoparticle formulations designed for cancer imaging and/or cancer treatment to overcome specific barriers and shift the accumulation of payloads toward the diseased tissues. In recent years, novel technological and chemical approaches have been employed to modify or functionalize the surface of nanoparticles or manipulate the characteristics of nanoparticles. Combining these approaches with the identification of critical biomarkers provides new strategies for enhancing nanoparticle specificity for both cancer diagnostic and therapeutic applications. This review discusses the most recent advances in the design and engineering of nanoparticles as well as future directions for developing the next generation of nanomedicines. |
|---|---|
| AbstractList | Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However, nanoparticles are still subject to biological barriers and biodistribution challenges, which limit their overall clinical potential. This has motivated the implementation of innovational modifications to a range of nanoparticle formulations designed for cancer imaging and/or cancer treatment to overcome specific barriers and shift the accumulation of payloads toward the diseased tissues. In recent years, novel technological and chemical approaches have been employed to modify or functionalize the surface of nanoparticles or manipulate the characteristics of nanoparticles. Combining these approaches with the identification of critical biomarkers provides new strategies for enhancing nanoparticle specificity for both cancer diagnostic and therapeutic applications. This review discusses the most recent advances in the design and engineering of nanoparticles as well as future directions for developing the next generation of nanomedicines. Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However, nanoparticles are still subject to biological barriers and biodistribution challenges, which limit their overall clinical potential. This has motivated the implementation of innovational modifications to a range of nanoparticle formulations designed for cancer imaging and/or cancer treatment to overcome specific barriers and shift the accumulation of payloads toward the diseased tissues. In recent years, novel technological and chemical approaches have been employed to modify or functionalize the surface of nanoparticles or manipulate the characteristics of nanoparticles. Combining these approaches with the identification of critical biomarkers provides new strategies for enhancing nanoparticle specificity for both cancer diagnostic and therapeutic applications. This review discusses the most recent advances in the design and engineering of nanoparticles as well as future directions for developing the next generation of nanomedicines.Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However, nanoparticles are still subject to biological barriers and biodistribution challenges, which limit their overall clinical potential. This has motivated the implementation of innovational modifications to a range of nanoparticle formulations designed for cancer imaging and/or cancer treatment to overcome specific barriers and shift the accumulation of payloads toward the diseased tissues. In recent years, novel technological and chemical approaches have been employed to modify or functionalize the surface of nanoparticles or manipulate the characteristics of nanoparticles. Combining these approaches with the identification of critical biomarkers provides new strategies for enhancing nanoparticle specificity for both cancer diagnostic and therapeutic applications. This review discusses the most recent advances in the design and engineering of nanoparticles as well as future directions for developing the next generation of nanomedicines. [Display omitted] •Progress of preclinical and clinical research into engineered nanomedicine is helping to bring new effective diagnostic and therapeutic approaches to cancer patients.•Biomarker-driven engineered nanoparticles offer enhanced cancer-specific and personalized therapy.•Engineered nanoparticles represent an efficient tool to deliver different types of treatments for patients with difficult-to-treat cancers.•Surface-engineered nanoparticles have the potential to overcome the physical and biological barriers that are known to limit the effectiveness of unmodified or unfunctionalized nanoparticles. Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However, nanoparticles are still subject to biological barriers and biodistribution challenges, which limit their overall clinical potential. This has motivated the implementation of innovational modifications to a range of nanoparticle formulations designed for cancer imaging and/or cancer treatment to overcome specific barriers and shift the accumulation of payloads toward the diseased tissues. In recent years, novel technological and chemical approaches have been employed to modify or functionalize the surface of nanoparticles or manipulate the characteristics of nanoparticles. Combining these approaches with the identification of critical biomarkers provides new strategies for enhancing nanoparticle specificity for both cancer diagnostic and therapeutic applications. This review discusses the most recent advances in the design and engineering of nanoparticles as well as future directions for developing the next generation of nanomedicines. |
| ArticleNumber | 114482 |
| Author | Wafa, Emad I. Salem, Aliasger K. Alhaj-Suliman, Suhaila O. |
| Author_xml | – sequence: 1 givenname: Suhaila O. surname: Alhaj-Suliman fullname: Alhaj-Suliman, Suhaila O. organization: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, United States – sequence: 2 givenname: Emad I. surname: Wafa fullname: Wafa, Emad I. organization: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, United States – sequence: 3 givenname: Aliasger K. surname: Salem fullname: Salem, Aliasger K. email: aliasger-salem@uiowa.edu organization: Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA 52242, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35944587$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kD1LBDEQQIMoen78AQvZ0mbPZJLdZMFGxC8QbRTsQi6ZPXLcJprkBP-9e55aWFgNDO8NzNsn2yEGJOSY0SmjrD1bTI1zaQoUYMqYEAq2yIQpCbWCTmyTyQh1taDdyx7Zz3lBKQPZ0l2yx5tOiEbJCXm4CnMfEJMP8yqYEPNHLjjkqsQqvmOyccBqZlLymL6W1gSLqXLezEfY58oEV5WEpgwYyiHZ6c0y49H3PCDP11dPl7f1_ePN3eXFfW1505ZaMmhmlvd9S2WveE8tA3BcillHlZKN4LxnHUMH0ApjVQvQWYPUwvidEZIfkNPN3dcU31aYix58trhcmoBxlTVISlsBLV-jJ9_oajag06_JDyZ96J8GIwAbwKaYc8L-F2FUr0PrhV6H1uvQehN6lNQfyfpiio-hJOOX_6vnGxXHQO9jV52tx7Gq8wlt0S76__RPvpuX9w |
| CitedBy_id | crossref_primary_10_1016_j_biomaterials_2023_122093 crossref_primary_10_1039_D3NR03161F crossref_primary_10_1016_j_talanta_2023_124548 crossref_primary_10_1016_j_addr_2022_114669 crossref_primary_10_1007_s10555_023_10142_x crossref_primary_10_1016_j_ijpharm_2024_123976 crossref_primary_10_1016_j_dyepig_2023_111603 crossref_primary_10_1016_j_ijpharm_2024_124800 crossref_primary_10_3892_ol_2024_14298 crossref_primary_10_1080_03007995_2024_2416985 crossref_primary_10_1016_j_biomaterials_2024_122469 crossref_primary_10_1016_j_biomaterials_2024_122801 crossref_primary_10_1016_j_ajps_2024_100980 crossref_primary_10_3390_pharmaceutics15051514 crossref_primary_10_1186_s43094_024_00686_2 crossref_primary_10_3390_ijms232214486 crossref_primary_10_3390_ijms24119293 crossref_primary_10_1016_j_ijpharm_2023_123729 crossref_primary_10_3390_pharmaceutics15071821 crossref_primary_10_1080_00222348_2023_2274668 crossref_primary_10_1002_smll_202302931 crossref_primary_10_1016_j_addr_2023_114897 crossref_primary_10_1016_j_biopha_2022_113998 crossref_primary_10_1016_j_biopha_2024_116925 crossref_primary_10_1002_mog2_67 crossref_primary_10_1002_smtd_202201307 crossref_primary_10_1002_smll_202300096 crossref_primary_10_1021_acs_langmuir_3c00491 crossref_primary_10_3390_pharmaceutics15020678 crossref_primary_10_1016_j_bioactmat_2024_03_001 crossref_primary_10_1021_acsanm_4c02319 |
| Cites_doi | 10.7150/thno.34576 10.1002/smll.201100628 10.1016/j.actbio.2018.04.006 10.3322/caac.21565 10.1021/mp400751g 10.1002/mabi.201900159 10.1200/JCO.2005.06.081 10.1021/acsanm.0c01148 10.1016/j.ijpharm.2016.11.012 10.2967/jnumed.107.049478 10.1016/j.aca.2017.08.003 10.1016/j.colsurfb.2016.01.019 10.5772/63437 10.2147/IJN.S112660 10.3892/mco.2014.356 10.1038/s41392-021-00572-w 10.1016/j.scp.2017.07.002 10.1016/j.jconrel.2008.05.010 10.1021/jacs.8b04511 10.1021/nn2026353 10.1126/sciadv.abb8725 10.1124/jpet.118.252809 10.2967/jnumed.110.084236 10.1038/s41408-021-00459-7 10.1155/2014/852748 10.1016/j.ijpharm.2021.120876 10.1002/advs.202103444 10.1038/aps.2017.34 10.3390/cancers11111783 10.3389/fimmu.2018.00978 10.1016/j.ijpharm.2010.10.041 10.1021/acs.bioconjchem.0c00347 10.3390/biom9060218 10.1038/s41416-020-01157-0 10.1007/s10549-019-05505-4 10.3390/biom9080330 10.3390/ijms17091440 10.1016/j.addr.2020.06.025 10.1016/j.jcis.2010.10.054 10.1016/j.biocel.2019.105567 10.1016/j.actbio.2020.05.028 10.1021/acssensors.8b00726 10.3390/ijms21176018 10.1016/j.jconrel.2006.11.015 10.1016/j.eurpolymj.2021.110356 10.1021/am500761x 10.1016/j.ijpharm.2015.09.065 10.1073/pnas.1011379108 10.1021/acsnano.7b07214 10.1080/15685551.2019.1699727 10.1016/j.jconrel.2011.08.015 10.1016/j.jconrel.2011.03.017 10.1038/nbt.3330 10.1016/j.curtheres.2010.08.005 10.3109/09553002.2016.1145360 10.3390/molecules26113382 10.1021/acsbiomaterials.7b00648 10.1016/j.canlet.2004.03.038 10.1002/biot.200600050 10.1042/BJ20101603 10.1186/s13550-016-0175-x 10.2217/nnm.15.32 10.1021/ie9011479 10.1517/17425247.2015.966684 10.1007/978-1-4939-6445-1_14 10.1016/j.biopha.2018.09.039 10.1155/2015/320941 10.1016/j.ijpharm.2021.120268 10.3390/cancers13051072 10.1016/j.biomaterials.2017.12.018 10.3390/pharmaceutics10030151 10.1016/j.ctrv.2018.06.011 10.1038/s41392-021-00670-9 10.1038/s41392-021-00659-4 10.1016/j.actbio.2015.02.022 10.1016/j.msec.2020.110768 10.2217/nnm-2021-0194 10.1016/j.biomaterials.2017.10.048 10.1186/s12885-021-08296-4 10.3389/fphar.2019.00808 10.1158/0008-5472.CAN-06-2354 10.1038/nnano.2017.57 10.1080/19336918.2020.1766308 10.3390/cells8060540 10.1021/ac0707075 10.1016/j.talanta.2006.07.027 10.7150/ntno.22091 10.1016/j.biomaterials.2019.119637 10.6058/jlc.2011.10.2.69 10.1038/s41568-019-0238-1 10.3390/cells10051154 10.1038/s41568-018-0038-z 10.1016/j.biomaterials.2010.01.009 10.1016/j.biomaterials.2014.01.011 10.2147/DDDT.S86764 10.1039/C7SC04853J 10.1016/j.nano.2011.08.017 10.1186/s11671-015-0873-8 10.1038/s41598-020-58730-z 10.1186/s12943-021-01341-7 10.1021/acsomega.9b03594 10.1038/s41573-020-0090-8 10.1039/C6CS00636A 10.1016/j.nano.2015.10.001 10.1016/j.ygyno.2006.10.063 10.3892/or.2014.2981 10.1038/s41577-020-0306-5 10.1146/annurev-bioeng-112315-031200 10.1080/10611860802088630 10.7150/ijms.49801 10.1152/ajprenal.90601.2008 10.1021/acs.jpcb.5b02891 10.1002/chem.201100658 10.1016/j.jconrel.2005.03.027 10.1016/j.bpj.2018.07.038 10.3389/fphar.2015.00286 10.1016/j.addr.2012.09.037 10.1016/j.jconrel.2021.03.013 10.1038/nbt1377 10.1007/s11095-016-1958-5 10.1016/j.celrep.2017.10.030 10.1117/1.JBO.17.12.126004 10.3390/molecules25173982 10.1016/j.jconrel.2017.01.011 10.2147/IJN.S139011 10.1002/btm2.10143 10.1039/C8RA02095G 10.1038/nnano.2016.239 10.1021/acs.biomac.7b00046 10.1517/14728222.2016.1164694 10.1602/neurorx.1.2.182 10.1002/adfm.201905671 10.1038/nrc3627 10.1016/j.biomaterials.2011.07.004 10.1021/ar7000815 10.1155/2013/926295 10.3322/caac.21654 10.1016/j.molmed.2021.04.002 10.1097/CAD.0b013e32834a4554 10.1016/j.jphotobiol.2015.05.008 10.3389/fendo.2021.679000 10.4143/crt.2016.376 10.1021/acsnano.6b06477 10.1016/j.nano.2005.06.004 10.1038/aps.2017.45 10.3390/ijms18102142 10.1054/ejon.2000.0070 10.1007/s11095-014-1598-6 10.1021/ja4124412 10.3390/pharmaceutics13050638 10.1021/acs.analchem.9b02403 10.1021/acs.biomac.6b01704 10.1200/JCO.2005.04.937 10.3389/fmolb.2020.00193 10.1038/s41598-019-44569-6 10.1056/NEJMp2007839 10.1016/j.cclet.2020.11.029 10.1126/sciadv.abk3150 10.1016/j.actbio.2019.12.005 10.1021/acs.biomac.1c00649 10.2147/IJN.S250490 10.1016/j.ijpharm.2019.118814 10.1097/MPA.0000000000000194 10.1038/srep11760 10.4174/astr.2015.89.1.1 10.1021/nl204175t 10.1021/acs.bioconjchem.6b00611 10.1016/j.jconrel.2018.09.031 10.1097/MD.0000000000005772 10.1021/acs.biomac.9b01754 10.1208/s12249-013-0041-3 10.1038/bjc.2015.8 10.2165/00003088-200342050-00002 10.1016/j.biopha.2020.110236 10.2217/imt.12.112 10.1080/2162402X.2020.1738813 10.1016/j.actbio.2017.01.005 10.1056/NEJMoa1817323 10.1007/s10620-014-3201-8 10.1088/0957-4484/26/7/075101 10.1016/j.peptides.2015.04.026 10.1021/acs.molpharmaceut.5b00946 10.1002/mabi.201400035 10.1002/anie.200801076 10.1038/s41565-017-0009-7 10.1016/j.ctrv.2020.102064 10.1021/acsptsci.0c00096 10.1038/s41416-019-0705-1 10.1002/ijc.22811 10.1016/j.vaccine.2020.02.086 10.1016/j.addr.2020.07.022 10.3322/caac.21660 10.1098/rsif.2014.0459 10.2174/156800909789057006 10.1517/14728222.2011.648617 10.1677/erc.0.0090075 10.1021/acs.bioconjchem.1c00479 10.1021/acs.nanolett.6b04150 10.1039/C4CS00370E 10.1016/j.jconrel.2021.02.016 10.1155/2013/420480 10.1038/s41598-017-04229-z 10.1021/jacs.6b13132 10.1186/s12951-018-0392-8 10.1002/wnan.1409 10.1016/j.addr.2018.07.011 10.1016/j.ygyno.2007.05.018 10.1002/adma.201705328 10.1038/natrevmats.2016.14 10.1016/j.actbio.2019.11.027 10.1016/j.jconrel.2007.05.011 10.1186/s13045-019-0760-3 10.1021/acs.molpharmaceut.1c00046 10.1038/nrg3763 10.1158/1535-7163.MCT-17-1299 10.1146/annurev-physiol-021119-034627 10.3390/pharmaceutics12111028 10.1039/C9TB02411E 10.1016/j.gpb.2017.03.001 10.1007/s13346-013-0167-6 10.1021/acsami.5b12463 10.1038/srep27559 10.1016/j.biomaterials.2013.01.078 10.2147/IJN.S226628 10.2147/IJN.S149887 10.1186/s13052-018-0563-0 10.1016/S1470-2045(21)00660-4 10.1002/pmic.200701072 10.1002/btm2.10246 10.3390/pharmaceutics12070604 10.3109/10611860903508796 10.1039/C9RE00474B 10.1021/acs.biomac.9b01026 10.1021/mp500698b 10.1016/j.biomaterials.2017.10.035 10.1016/B978-0-12-407173-5.00002-9 10.7150/thno.64805 10.1021/acs.biomac.9b01257 10.1016/j.jconrel.2014.07.040 10.3389/fphar.2013.00143 10.1016/j.apmt.2018.05.002 10.1016/j.ejps.2016.07.007 10.1021/nn301218z 10.1039/C4NR01564A 10.1016/j.addr.2015.09.012 10.1021/ac9011073 10.1177/0046958019880696 10.3892/or.2015.4136 10.1016/j.ab.2004.12.026 10.1021/ja805570f 10.3389/fphar.2018.00202 10.1002/adfm.201303253 10.3892/ol.2014.2449 10.2147/IJN.S146315 10.1021/nn203833d 10.1039/c0jm01544j 10.1039/C5BM00037H 10.1016/j.carres.2015.11.003 10.1002/jcp.21494 10.1021/acsami.9b17749 10.3390/ijms222313160 10.1002/adma.201603239 10.1038/s41598-019-39843-6 10.1056/NEJM200105033441806 10.1007/s00604-012-0816-3 10.2147/IJN.S137833 10.1186/s12935-019-1067-8 10.1016/j.ceb.2013.11.003 10.1021/acsnano.5b01552 10.1186/s11671-020-03309-w 10.1007/s12274-019-2308-9 10.1038/onc.2014.314 10.3109/13880209.2013.874533 10.7150/thno.17098 10.1016/j.biomaterials.2014.12.028 10.2147/DDDT.S235098 10.1002/jcp.24791 10.1038/s41598-020-58527-0 10.1080/14789450.2018.1450631 10.1021/ja0776529 10.1016/j.biomaterials.2017.06.021 10.1155/2013/546318 10.1166/jbn.2013.1536 10.2967/jnumed.107.043703 10.1039/C8CS00162F 10.3390/nano11010177 10.1161/CIRCRESAHA.107.155655 10.1007/s00604-017-2410-1 10.1007/s00216-018-1501-0 10.1038/onc.2011.602 |
| ContentType | Journal Article |
| Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.addr.2022.114482 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1872-8294 |
| ExternalDocumentID | 35944587 10_1016_j_addr_2022_114482 S0169409X22003726 |
| Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIDCR NIH HHS grantid: R21 DE031042 – fundername: NCI NIH HHS grantid: P30 CA086862 |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23M 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HX~ HZ~ IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSU SSZ T5K TEORI WUQ Y6R ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c356t-7125bc3ff607f83f0c122d374b908875433f191ed2264ac86229cae0c2872a473 |
| IEDL.DBID | .~1 |
| ISSN | 0169-409X 1872-8294 |
| IngestDate | Fri Jul 11 02:43:56 EDT 2025 Wed Feb 19 02:25:48 EST 2025 Thu Apr 24 23:08:57 EDT 2025 Tue Jul 01 03:36:09 EDT 2025 Fri Feb 23 02:40:41 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Drug delivery and targeting Surface engineering Engineered nanoparticles Cancer therapy Surface-functionalization Surface chemistry Tumor-targeted nanoparticles Surface-modification Nanomedicine Cancer imaging and diagnosis |
| Language | English |
| License | Copyright © 2022 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c356t-7125bc3ff607f83f0c122d374b908875433f191ed2264ac86229cae0c2872a473 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 35944587 |
| PQID | 2700642637 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2700642637 pubmed_primary_35944587 crossref_primary_10_1016_j_addr_2022_114482 crossref_citationtrail_10_1016_j_addr_2022_114482 elsevier_sciencedirect_doi_10_1016_j_addr_2022_114482 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | October 2022 2022-10-00 20221001 |
| PublicationDateYYYYMMDD | 2022-10-01 |
| PublicationDate_xml | – month: 10 year: 2022 text: October 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Advanced drug delivery reviews |
| PublicationTitleAlternate | Adv Drug Deliv Rev |
| PublicationYear | 2022 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Kratz (b0425) 2008; 132 Yang, Yan, Liu (b0795) 2018; 9 Qin, Wang, Fan, Zhang, Zhang, Lv, Cui (b0760) 2014; 8 Doolittle, Peiris, Doron, Goldberg, Tucci, Rao, Shah, Sylvestre, Govender, Turan, Lee, Schiemann, Karathanasis (b1290) 2015; 9 Maurel, Montheil, Martin, Chaar, Guzman-Gonzalez, Couvet, Jacquet, Jia, Eymin, Parra, Dumy, Martinez, Ruggiero, Vaganay, Mehdi, Coll, Subra (b1300) 2021; 11 Yang, Lu, Li, Lu (b0580) 2020; 14 Mahabeleshwar, Feng, Reddy, Plow, Byzova (b0645) 2007; 101 Slamon (b1045) 2000; 4 Zheng, Xie, Zhang, Sun, Zhao, Li, Wang (b0315) 2021; 32 Hashemzadeh, Javadi, Darvishi (b0150) 2020; 10 Wafa, Geary, Ross, Goodman, Narasimhan, Salem (b0215) 2019; 21 Talekar, Kendall, Denny, Garg (b0900) 2011; 22 Sandoval, Sloat, Lansakara, Kumar, Rodriguez, Kiguchi, Digiovanni, Cui (b0525) 2012; 157 Zheng, Luo, Chen, Li, Huang, Zhou, Zhu, Kang, Geng (b1105) 2021; 20 Fortin, Genevois, Koenig, Heinrich, Texier, Couillaud (b1155) 2012; 17 Angelopoulou, Kolokithas-Ntoukas, Fytas, Avgoustakis (b1245) 2019; 4 Zhang, Darmon, Marill, Mohamed Anesary, Paris (b1545) 2020; 15 Ghosh, Biswas (b0295) 2021; 332 Yao, Zhou, Liu, Xu, Chen, Wang, Wu, Deng, Zhang, Shao (b0095) 2020; 7 Boedtkjer, Pedersen (b0330) 2020; 82 Dou, Wang, Zhang, Wang, Xu, Xu, Xu, Xiang, Fu, Song (b1215) 2018; 13 Miller, Nogueira, Mariotto, Rowland, Yabroff, Alfano, Jemal, Kramer, Siegel (b0020) 2019; 69 Swider, Koshkina, Tel, Cruz, de Vries, Srinivas (b0200) 2018; 73 Iqbal, Iqbal (b0515) 2014; 2014 Zhao, Zeng (b0135) 2015; 10 Mayeux (b0935) 2004; 1 Lin, Xu, Lan (b1475) 2019; 12 Li, He, Sun, Luo, Cai, Pan, Shen, Xia, Shi (b1100) 2014; 35 Liu, Gu, Liang, Dai, Wan, Hong, Zhang, Liu (b1165) 2017; 12 Zhang, Beatty, Lu, Abdalrahman, Makris, Wang, Wang (b0245) 2020; 111 Wilson-Welder, Boggiatto, Nally, Wafa, Alt, Hornsby, Frank, Jones, Olsen, Bowden, Salem (b0265) 2020; 38 Kinoshita, Ishima, Chuang, Nakamura, Fang, Watanabe, Shimizu, Okuhira, Ishida, Maeda, Otagiri, Maruyama (b0410) 2017; 140 Pooresmaeil, Namazi (b1390) 2021; 148 Shieh, Hsu, Huang, Chen, Huang, Lai (b0830) 2011; 152 Krook, Reeser, Ernst, Barker, Wilberding, Li, Chen, Roychowdhury (b0590) 2021; 124 Hamidi, Ivaska (b0640) 2018; 18 J. Zhang, Y. Lin, Z. Lin, Q. Wei, J. Qian, R. Ruan, X. Jiang, L. Hou, J. Song, J. Ding, H. Yang, Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy, Adv. Sci. n/a 2103444. Song, Falzone, Vallis (b0520) 2016; 92 Gokarna, Jin, Hwang, Cho, Lim, Chung, Youn, Choi, Lim (b0960) 2008; 8 Harries, Smith (b1040) 2002; 9 Lee, Kim, Cho, Kim, Kim, Hur, Kim, Kim, Kim, Ryu, Kang (b0310) 2018; 50 Wafa, Wilson-Welder, Hornsby, Nally, Geary, Bowden, Salem (b0270) 2020; 21 Kim, Araujo, Howard, Magni, Liotta, Luchini (b0930) 2018; 15 Smith, Stephan, Moffett, McKnight, Ji, Reiman, Bonagofski, Wohlfahrt, Pillai, Stephan (b1520) 2017; 12 Lv, Zhang, Shuaizhen, Yu, Zheng (b0650) 2020; 128 Tian, Huang, Zhao, Zhao (b0970) 2012; 178 Bazak, Houri, Achy, Hussein, Refaat (b0480) 2014; 2 Zhao, Wang, Kang, Wu, Yin, Tang, Wang, Zhang, Duan, Huang (b1480) 2018; 9 Behzadi, Serpooshan, Tao, Hamaly, Alkawareek, Dreaden, Brown, Alkilany, Farokhzad, Mahmoudi (b0070) 2017; 46 Ding, Tang, Cao, Wu, Yuan, Qiao, Pan, Hu (b0430) 2014; 15 Moreno, Ramos-Alvarez, Moody, Jensen (b0690) 2016; 20 Barbieri, Bajetto, Pattarozzi, Gatti, Wurth, Thellung, Corsaro, Villa, Nizzari, Florio (b0675) 2013; 2013 Zhuo, Yu, Wang, Li, Zhang, Liu, Wu, Lu, Zhang, Zhang (b0490) 2017; 18 Santi, Maccari, Mereghetti, Voliani, Rocchiccioli, Ucciferri, Luin, Signore (b0755) 2017; 28 Satchell, Braet (b0470) 2009; 296 Miller-Kleinhenz, Guo, Qian, Zhou, Bozeman, Zhu, Ji, Wang, Styblo, O'Regan, Mao, Yang (b1275) 2018; 152 Wang, Zheng, Yang, Zhu, Zhu, Wang, Wu, Zhou, Yan, Hu, Kong, Fu, Bruns, Zhao, Qin, Dong (b0485) 2021; 6 Alhaj-Suliman, Wafa, Geary, Salem (b0220) 2019; 22 Guo, Gao, Su, Xia, Gu, Pang, Jiang, Yao, Chen, Chen (b1225) 2011; 32 Liu, Koblish, Wu, Bowman, Diamond, DiMatteo, Zhang, Hansbury, Rupar, Wen, Collier, Feldman, Klabe, Burke, Soloviev, Gardiner, He, Volgina, Covington, Ruggeri, Wynn, Burn, Scherle, Yeleswaram, Yao, Huber, Hollis (b0605) 2020; 15 Tong, Yala, Fan, Cheng (b0440) 2010; 31 Banu, Sethi, Edgar, Sheriff, Rayees, Renuka, Faheem, Premkumar, Vasanthakumar (b1260) 2015; 149 Sterner, Sterner (b1515) 2021; 11 Deng, Xu, Hu, Xun, Zheng, Su (b1540) 2018; 154 Anselmo, Mitragotri (b0280) 2021 Qin, Lee, Ray, Kopelman (b0850) 2014; 14 Mardhian, Storm, Bansal, Prakash (b1500) 2018; 290 Abedi-Gaballu, Dehghan, Ghaffari, Yekta, Abbaspour-Ravasjani, Baradaran, Dolatabadi, Hamblin (b0325) 2018; 12 D’Arcangelo, Wu, Cadavid, McGuigan (b1485) 2020; 122 Anselmo, Mitragotri (b0275) 2019; 4 Jalilzadeh, Samadi, Salehi, Dehghan, Iranshahi, Dadpour, Hamishehkar (b0255) 2020; 10 Poudineh, Aldridge, Ahmed, Green, Kermanshah, Nguyen, Tu, Mohamadi, Nam, Hansen, Sridhar, Finelli, Fleshner, Joshua, Sargent, Kelley (b0990) 2017; 12 Yang, Chang, Shin, Park, Na, Shim (b1120) 2010; 20 Szulc, Signorelli, Schiraldi, Appelhans, Voit, Bryszewska, Klajnert-Maculewicz, Fessas (b1380) 2015; 495 Zhou, Chen, Yang, Bao, Fan, Wang, Lin, Zhu (b0380) 2020; 8 Lu, Wan, She, Jiang (b1425) 2007; 118 Lee, Shin, Shin, Chun, Park (b0585) 2019; 9 Zhou, Zhao, Ma, Ju, Li, Li, Sun, Shi, Zhang, Lu (b0835) 2013; 34 BEST (Biomarkers, EndpointS, and other Tools) Resource, Silver Spring (MD), 2016. Gulcur, Thaqi, Khaja, Kuzmis, Onyuksel (b0740) 2013; 3 Ebeid, Meng, Thiel, Do, Geary, Morris, Pham, Wongrakpanich, Chhonker, Murry, Leslie, Salem (b0840) 2018; 13 Li, Zhang, Liu, He (b0305) 2019; 10 Wiwatchaitawee, Ebeid, Quarterman, Naguib, Ali, Oliva, Griguer, Salem (b0860) 2022 Gross, Chitphet, Wongrakpanich, Wafa, Norian, Salem (b1455) 2020; 31 Zhang, Hong, Zhang, Chen, Li, Dai, Wang (b1135) 2012; 6 Cheng, Deng, Lin, Cai, Zink (b0105) 2019; 9 Liu, Kshirsagar, Gautam, Gulati, Wafa, Christiansen, White, Mallapragada, Wannemuehler, Kumar, Solheim, Batra, Salem, Narasimhan, Jain (b0260) 2022; 12 Pooja, Gunukula, Gupta, Adams, Kulhari (b0685) 2019; 114 Kerman, Endo, Tsukamoto, Chikae, Takamura, Tamiya (b0950) 2007; 71 Jafari, Salouti, Shayesteh, Heidari, Rajabi, Boustani, Nahardani (b1085) 2015; 26 Ramos, Bentires-Alj (b0035) 2015; 34 Wu, Opadele, Onodera, Nam (b1525) 2019; 11 Maecke, Reubi (b0680) 2011; 52 Zhang, Aruva, Shanthly, Cardi, Rattan, Patel, Kim, McCue, Wickstrom, Thakur (b0725) 2008; 49 Feng, Chen, Wu, Que, Tamburini, Baldazzi, Chang, Zhang (b1055) 2020; 230 Ortner, Wernig, Kaisler, Edetsberger, Hajos, Kohler, Mosgoeller, Zimmer (b0735) 2010; 18 Wafa, Geary, Ross, Goodman, Narasimhan, Salem (b0210) 2019; 370 Li, Pang, Liu (b0290) 2018; 4 Hartmann, Keeney, Lingle, Christianson, Varghese, Hillman, Oberg, Low (b0615) 2007; 121 Korc, Friesel (b0560) 2009; 9 Esmaeili, Ghahremani, Ostad, Atyabi, Seyedabadi, Malekshahi, Amini, Dinarvand (b1240) 2008; 16 Lu, Zhang, Tan, Hu, Jiang, Fu (b1415) 2005; 107 Chen, Chen, He (b1345) 2019; 47 Nel, Ruoslahti, Meng (b0465) 2017; 11 Papanicolas, Sims, Taylor, Miller, Karapetis, Wesselingh, Gordon, Rogers (b0050) 2021; 21 Alexander-Bryant, Vanden Berg-Foels, Wen (b0775) 2013; 118 Hsu, Bugno, Lee, Hong (b0320) 2017; 9 F. Xu, X. Li, X. Huang, J. Pan, Y. Wang, S. Zhou, Development of a pH-responsive polymersome inducing endoplasmic reticulum stress and autophagy blockade, Sci Adv, 6 (2020) eabb8725. Schilsky, Nass, Le Beau, Benz (b0015) 2020; 383 Abdel-Rahman, El-Damasy, Hassan, Wafa, Geary, Maarouf, Salem (b0040) 2020; 3 Song, Ren, Zhang, Wang, Han, Zheng, Zhen (b1210) 2015; 34 Gradishar, Tjulandin, Davidson, Shaw, Desai, Bhar, Hawkins, O'Shaughnessy (b0450) 2005; 23 Nazari, Zamani Koukhaloo, Mousavi, Minai-Tehrani, Emamzadeh, Cheraghi (b0555) 2019; 19 Wesche, Haglund, Haugsten (b0575) 2011; 437 Dang, Zhang, Li, Hu, Li, Li, Wei, Shi (b0780) 2017; 96 Liu, Wang, Xu, Guo, Wen, Huang, Liu, Shen, Zhao, Zhang, Shi (b1075) 2014; 6 Maslowska, Halik, Tymecka, Misicka, Gniazdowska (b0785) 2021; 13 Seferos, Giljohann, Hill, Prigodich, Mirkin (b1110) 2007; 129 Jin, Wang, Oppong-Gyebi, Hu (b0940) 2020; 17 Dieci, Miglietta, Griguolo, Guarneri (b0540) 2020; 88 Yonezawa, Koide, Asai (b0180) 2020; 154–155 Smith, Cooper, McGovern, Gilius, Zhong, Liao, Molinolo, Gutkind, Matters (b0705) 2014; 43 Suk, Xu, Kim, Hanes, Ensign (b0500) 2016; 99 Wang (b1205) 2020; 14 J. Park, K.A. Look, Health Care Expenditure Burden of Cancer Care in the United States, Inquiry, 56 (2019) 46958019880696. Din, Aman, Ullah, Qureshi, Mustapha, Shafique, Zeb (b1175) 2017; 12 Yang, Liang, Ma, Wang, Huang (b0090) 2019; 22 Huang, Chiu, Huang, Chang (b0975) 2007; 79 Wafa, Geary, Goodman, Narasimhan, Salem (b0205) 2017; 50 Rinderknecht, Detmar (b1145) 2008; 216 Chen, Estevez, Zhu, Huang, Chen, Wang, Tan (b1050) 2009; 81 Fisher, Siegel, Edell, Oyesiku, Morgenstern, Messmann, Amato (b0635) 2008; 49 Bugno, Hsu, Pearson, Noh, Hong (b0335) 2016; 13 Lee, Jeong, Han, Baek (b0765) 2015; 89 Lu, Sun, Wan, She, Jiang (b1430) 2006; 66 Khongkow, Yata, Boonrungsiman, Ruktanonchai, Graham, Namdee (b0855) 2019; 9 Li, Shi, Zhang, Ou, Ma, Chen, Shu, Li, Wang (b1470) 2021; 6 Schadlich, Caysa, Mueller, Tenambergen, Rose, Gopferich, Kuntsche, Mader (b1160) 2011; 5 Chen, Chen, Zhao, Kuznetsova, Wong, Ojima (b1460) 2008; 130 Duan, Dhar, Patel, Khimani, Neogi, Sharma, Siva Kumar, Vekariya (b0195) 2020; 10 Wu, Onodera, Ichikawa, Rankin, Giaccia, Watanabe, Qian, Hashimoto, Shirato, Nam (b1530) 2017; 12 Santa-Maria, Walter, Valkai, Bras, Meszaros, Kincses, Klepe, Gaspar, Castanho, Zimanyi, Der, Deli (b1420) 1861; 2019 Cui, Xu, Davoodi, Wang, Wang (b1230) 2017; 38 Wang, Tong, Zhang, Zhang, Buzdin, Mu, Yan, Zhao, Chang, Duhon, Zhou, Zhao, Chen, Li (b0925) 2021; 11 Allen, Cullis (b0890) 2013; 65 Allard, Risinger, Morrison, Young, Rose, Fowler, Berchuck, Maxwell (b0625) 2007; 107 Ahmad, Cisewski, Minino, Anderson (b0025) 2020; 70 Albuquerque, Sincari, Jäger, Kucka, Humajova, Pankrac, Paral, Heizer, Janouškova, Davidovich, Talmon, Pouckova, Štěpánek, Sefc, Hruby, Giacomelli, Jäger (b0360) 2021; 332 Cui, Ji, Sun, Wang, Wang, Zhang, Ding, Lu, Xu, Sun (b1020) 2019; 411 Jacob, James, Hasmann, Weisser (b0550) 2018; 68 Grapa, Mocan, Goncia Wesche (10.1016/j.addr.2022.114482_b0575) 2011; 437 Xie (10.1016/j.addr.2022.114482_b0805) 2017; 7 Papanicolas (10.1016/j.addr.2022.114482_b0050) 2021; 21 Poudineh (10.1016/j.addr.2022.114482_b0990) 2017; 12 Cruz (10.1016/j.addr.2022.114482_b1450) 2014; 192 Dieci (10.1016/j.addr.2022.114482_b0540) 2020; 88 Seferos (10.1016/j.addr.2022.114482_b1110) 2007; 129 Shah (10.1016/j.addr.2022.114482_b0875) 2018; 115 Miller (10.1016/j.addr.2022.114482_b0020) 2019; 69 Zhou (10.1016/j.addr.2022.114482_b0380) 2020; 8 Zhang (10.1016/j.addr.2022.114482_b1235) 2011; 354 Ramos (10.1016/j.addr.2022.114482_b0035) 2015; 34 Sarfraz (10.1016/j.addr.2022.114482_b0145) 2018; 10 Hua (10.1016/j.addr.2022.114482_b0160) 2013; 4 Sun (10.1016/j.addr.2022.114482_b1195) 2015; 9 Chen (10.1016/j.addr.2022.114482_b1345) 2019; 47 Nazari (10.1016/j.addr.2022.114482_b0555) 2019; 19 Damborska (10.1016/j.addr.2022.114482_b0945) 2017; 184 Zhong (10.1016/j.addr.2022.114482_b1170) 2021; 6 Rideau (10.1016/j.addr.2022.114482_b0400) 2018; 47 de Barros (10.1016/j.addr.2022.114482_b0225) 2017; 1494 Hu (10.1016/j.addr.2022.114482_b0350) 2017; 18 Callison (10.1016/j.addr.2022.114482_b0665) 2011; 10 Tian (10.1016/j.addr.2022.114482_b0970) 2012; 178 Lin (10.1016/j.addr.2022.114482_b1475) 2019; 12 Pacini (10.1016/j.addr.2022.114482_b0570) 2021; 10 Tong (10.1016/j.addr.2022.114482_b0865) 2016; 6 Mitchell (10.1016/j.addr.2022.114482_b0075) 2021; 20 Yao (10.1016/j.addr.2022.114482_b0095) 2020; 7 Son (10.1016/j.addr.2022.114482_b0140) 2016; 11 Santa-Maria (10.1016/j.addr.2022.114482_b1420) 1861; 2019 Chen (10.1016/j.addr.2022.114482_b1050) 2009; 81 Zhi (10.1016/j.addr.2022.114482_b0130) 2020; 102 Cho (10.1016/j.addr.2022.114482_b0980) 2012; 6 Ghosh (10.1016/j.addr.2022.114482_b0295) 2021; 332 Alexander-Bryant (10.1016/j.addr.2022.114482_b0775) 2013; 118 Wu (10.1016/j.addr.2022.114482_b1250) 2014; 52 Perez-Lopez (10.1016/j.addr.2022.114482_b0460) 2020; 12 Deng (10.1016/j.addr.2022.114482_b1540) 2018; 154 Kim (10.1016/j.addr.2022.114482_b0930) 2018; 15 Padera (10.1016/j.addr.2022.114482_b1125) 2016; 18 Zhao (10.1016/j.addr.2022.114482_b1480) 2018; 9 Patra (10.1016/j.addr.2022.114482_b0085) 2018; 16 Kim (10.1016/j.addr.2022.114482_b0435) 2011; 403 Guo (10.1016/j.addr.2022.114482_b1225) 2011; 32 Szulc (10.1016/j.addr.2022.114482_b1380) 2015; 495 Zhuo (10.1016/j.addr.2022.114482_b0490) 2017; 18 Lee (10.1016/j.addr.2022.114482_b0765) 2015; 89 Cui (10.1016/j.addr.2022.114482_b1020) 2019; 411 Koo (10.1016/j.addr.2022.114482_b0445) 2005; 1 Barry (10.1016/j.addr.2022.114482_b0955) 2001; 344 Wang (10.1016/j.addr.2022.114482_b0925) 2021; 11 Alswieleh (10.1016/j.addr.2022.114482_b0815) 2019; 22 Suk (10.1016/j.addr.2022.114482_b0500) 2016; 99 Hartmann (10.1016/j.addr.2022.114482_b0615) 2007; 121 Thirunavukarasu (10.1016/j.addr.2022.114482_b0495) 2017; 139 Pooja (10.1016/j.addr.2022.114482_b0685) 2019; 114 Smith (10.1016/j.addr.2022.114482_b1520) 2017; 12 Wafa (10.1016/j.addr.2022.114482_b0210) 2019; 370 Moreno (10.1016/j.addr.2022.114482_b0690) 2016; 20 Swider (10.1016/j.addr.2022.114482_b0200) 2018; 73 Hamidi (10.1016/j.addr.2022.114482_b0640) 2018; 18 Zhou (10.1016/j.addr.2022.114482_b0835) 2013; 34 Wan (10.1016/j.addr.2022.114482_b1080) 2016; 419 Liu (10.1016/j.addr.2022.114482_b1075) 2014; 6 Mangal (10.1016/j.addr.2022.114482_b0060) 2017; 38 Angelopoulou (10.1016/j.addr.2022.114482_b1245) 2019; 4 Miller-Kleinhenz (10.1016/j.addr.2022.114482_b1275) 2018; 152 Harries (10.1016/j.addr.2022.114482_b1040) 2002; 9 Bobo (10.1016/j.addr.2022.114482_b0065) 2016; 33 Dou (10.1016/j.addr.2022.114482_b1215) 2018; 13 Hwang (10.1016/j.addr.2022.114482_b0340) 2015; 32 Fenton (10.1016/j.addr.2022.114482_b0190) 2018 Juan (10.1016/j.addr.2022.114482_b0655) 2020; 21 Siafaka (10.1016/j.addr.2022.114482_b0820) 2016; 17 El-Hammadi (10.1016/j.addr.2022.114482_b1270) 2017; 516 Hong (10.1016/j.addr.2022.114482_b0455) 2020; 12 Ahmed (10.1016/j.addr.2022.114482_b1280) 2017; 12 Maecke (10.1016/j.addr.2022.114482_b0680) 2011; 52 Spada (10.1016/j.addr.2022.114482_b0415) 2021; 18 Kerman (10.1016/j.addr.2022.114482_b0950) 2007; 71 Bisht (10.1016/j.addr.2022.114482_b0115) 2016; 3 Sercombe (10.1016/j.addr.2022.114482_b0185) 2015; 6 Wu (10.1016/j.addr.2022.114482_b1530) 2017; 12 Darmanis (10.1016/j.addr.2022.114482_b1395) 2017; 21 10.1016/j.addr.2022.114482_b0985 Doolittle (10.1016/j.addr.2022.114482_b1290) 2015; 9 Qian (10.1016/j.addr.2022.114482_b1070) 2008; 26 Bhana (10.1016/j.addr.2022.114482_b1005) 2015; 10 Zou (10.1016/j.addr.2022.114482_b0660) 2019; 17 Hu (10.1016/j.addr.2022.114482_b0670) 2021; 12 Siefker-Radtke (10.1016/j.addr.2022.114482_b0595) 2022; 23 Zhang (10.1016/j.addr.2022.114482_b1135) 2012; 6 Wang (10.1016/j.addr.2022.114482_b0895) 2018; 9 Yang (10.1016/j.addr.2022.114482_b0580) 2020; 14 Liu (10.1016/j.addr.2022.114482_b0260) 2022; 12 Dainty (10.1016/j.addr.2022.114482_b0630) 2007; 105 Allen (10.1016/j.addr.2022.114482_b0890) 2013; 65 Alhaj-Suliman (10.1016/j.addr.2022.114482_b0220) 2019; 22 Asadishad (10.1016/j.addr.2022.114482_b1255) 2010; 49 Makhov (10.1016/j.addr.2022.114482_b0045) 2018; 17 Kakarla (10.1016/j.addr.2022.114482_b1490) 2012; 4 Song (10.1016/j.addr.2022.114482_b0520) 2016; 92 Nie (10.1016/j.addr.2022.114482_b1060) 2020; 15 Esmaeili (10.1016/j.addr.2022.114482_b1240) 2008; 16 Yonezawa (10.1016/j.addr.2022.114482_b0180) 2020; 154–155 Yang (10.1016/j.addr.2022.114482_b0795) 2018; 9 Jafari (10.1016/j.addr.2022.114482_b1085) 2015; 26 Siegel (10.1016/j.addr.2022.114482_b0010) 2021; 71 Wu (10.1016/j.addr.2022.114482_b0915) 2015; 44 Zhen (10.1016/j.addr.2022.114482_b1505) 2017; 17 Barbieri (10.1016/j.addr.2022.114482_b0675) 2013; 2013 Ganesan (10.1016/j.addr.2022.114482_b0170) 2017; 6 Goel (10.1016/j.addr.2022.114482_b0790) 2013; 13 Ito (10.1016/j.addr.2022.114482_b1035) 2004; 212 Hashemzadeh (10.1016/j.addr.2022.114482_b0150) 2020; 10 Hoogenboezem (10.1016/j.addr.2022.114482_b0405) 2018; 130 Seshacharyulu (10.1016/j.addr.2022.114482_b0505) 2012; 16 Zhou (10.1016/j.addr.2022.114482_b0710) 2010; 71 Fontana (10.1016/j.addr.2022.114482_b0110) 2017; 29 Kratz (10.1016/j.addr.2022.114482_b0425) 2008; 132 Knox (10.1016/j.addr.2022.114482_b0250) 2020; 5 Yang (10.1016/j.addr.2022.114482_b0090) 2019; 22 Huang (10.1016/j.addr.2022.114482_b0975) 2007; 79 Satchell (10.1016/j.addr.2022.114482_b0470) 2009; 296 Waldman (10.1016/j.addr.2022.114482_b1445) 2020; 20 Jacob (10.1016/j.addr.2022.114482_b0550) 2018; 68 Ahmad (10.1016/j.addr.2022.114482_b0025) 2020; 70 Di Gioia (10.1016/j.addr.2022.114482_b1000) 2015; 112 Bazak (10.1016/j.addr.2022.114482_b0480) 2014; 2 Blanco (10.1016/j.addr.2022.114482_b0880) 2015; 33 Zhu (10.1016/j.addr.2022.114482_b0810) 2016; 8 Monteiro (10.1016/j.addr.2022.114482_b0155) 2014; 11 Lv (10.1016/j.addr.2022.114482_b0650) 2020; 128 Yin (10.1016/j.addr.2022.114482_b1340) 2014; 15 Dias (10.1016/j.addr.2022.114482_b0345) 2020; 573 Zhang (10.1016/j.addr.2022.114482_b0725) 2008; 49 Akkin (10.1016/j.addr.2022.114482_b1440) 2021; 26 Mayeux (10.1016/j.addr.2022.114482_b0935) 2004; 1 Liu (10.1016/j.addr.2022.114482_b1150) 2015; 12 Soetaert (10.1016/j.addr.2022.114482_b0125) 2020; 163–164 Zhang (10.1016/j.addr.2022.114482_b1355) 2019; 12 Nel (10.1016/j.addr.2022.114482_b0465) 2017; 11 Cui (10.1016/j.addr.2022.114482_b1230) 2017; 38 Abdel-Rahman (10.1016/j.addr.2022.114482_b0040) 2020; 3 Zhang (10.1016/j.addr.2022.114482_b0245) 2020; 111 Zhou (10.1016/j.addr.2022.114482_b1095) 2016; 140 Gao (10.1016/j.addr.2022.114482_b1295) 2014; 11 Das (10.1016/j.addr.2022.114482_b1335) 2015; 230 Cheng (10.1016/j.addr.2022.114482_b0100) 2013; 9 Dolen (10.1016/j.addr.2022.114482_b0885) 2020; 9 Lu (10.1016/j.addr.2022.114482_b1415) 2005; 107 Sahai (10.1016/j.addr.2022.114482_b1495) 2020; 20 Zhang (10.1016/j.addr.2022.114482_b1535) 2014; 6 Onaca (10.1016/j.addr.2022.114482_b0390) 2008; 47 Wu (10.1016/j.addr.2022.114482_b1525) 2019; 11 Schadlich (10.1016/j.addr.2022.114482_b1160) 2011; 5 Abdel-Rahman (10.1016/j.addr.2022.114482_b0235) 2021; 4 Yang (10.1016/j.addr.2022.114482_b1030) 2007; 120 10.1016/j.addr.2022.114482_b0825 Mahabeleshwar (10.1016/j.addr.2022.114482_b0645) 2007; 101 Bugno (10.1016/j.addr.2022.114482_b0335) 2016; 13 D’Arcangelo (10.1016/j.addr.2022.114482_b1485) 2020; 122 Puvvada (10.1016/j.addr.2022.114482_b1265) 2015; 5 10.1016/j.addr.2022.114482_b0030 Hao (10.1016/j.addr.2022.114482_b1065) 2018; 8 Lu (10.1016/j.addr.2022.114482_b1430) 2006; 66 Schilsky (10.1016/j.addr.2022.114482_b0015) 2020; 383 Chen (10.1016/j.addr.2022.114482_b1330) 2020; 112 Kinoshita (10.1016/j.addr.2022.114482_b0410) 2017; 140 Gradishar (10.1016/j.addr.2022.114482_b0450) 2005; 23 Huang (10.1016/j.addr.2022.114482_b1010) 2018; 2 Dou (10.1016/j.addr.2022.114482_b1015) 2019; 91 Parodi (10.1016/j.addr.2022.114482_b0420) 2019; 9 Sung (10.1016/j.addr.2022.114482_b0005) 2021; 71 Din (10.1016/j.addr.2022.114482_b1175) 2017; 12 Li (10.1016/j.addr.2022.114482_b1185) 2015; 18 Korc (10.1016/j.addr.2022.114482_b0560) 2009; 9 Feng (10.1016/j.addr.2022.114482_b1055) 2020; 230 Gross (10.1016/j.addr.2022.114482_b1455) 2020; 31 Anselmo (10.1016/j.addr.2022.114482_b0280) 2021 Khare (10.1016/j.addr.2022.114482_b1180) 2016; 92 Lu (10.1016/j.addr.2022.114482_b1425) 2007; 118 Kang (10.1016/j.addr.2022.114482_b1315) 2017; 11 Cheng (10.1016/j.addr.2022.114482_b0535) 2011; 7 Haen (10.1016/j.addr.2022.114482_b1435) 2020; 17 Banu (10.1016/j.addr.2022.114482_b1260) 2015; 149 Liu (10.1016/j.addr.2022.114482_b1165) 2017; 12 Ding (10.1016/j.addr.2022.114482_b0430) 2014; 15 Li (10.1016/j.addr.2022.114482_b1100) 2014; 35 Ebeid (10.1016/j.addr.2022.114482_b0840) 2018; 13 Jin (10.1016/j.addr.2022.114482_b1200) 2016; 6 Li (10.1016/j.addr.2022.114482_b0290) 2018; 4 LeCluyse (10.1016/j.addr.2022.114482_b0475) 2018 Cheng (10.1016/j.addr.2022.114482_b0720) 2013; 2013 Jalilzadeh (10.1016/j.addr.2022.114482_b0255) 2020; 10 Yang (10.1016/j.addr.2022.114482_b0995) 2019; 19 Kozlovskaya (10.1016/j.addr.2022.114482_b0370) 2019; 20 Thakur (10.1016/j.addr.2022.114482_b0730) 2004; 45 Smith (10.1016/j.addr.2022.114482_b0870) 2012; 12 Yang (10.1016/j.addr.2022.114482_b0300) 2014; 24 Albuquerque (10.1016/j.addr.2022.114482_b0360) 2021; 332 Qin (10.1016/j.addr.2022. |
| References_xml | – volume: 246 start-page: 183 year: 2017 end-page: 184 ident: b0080 article-title: Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond publication-title: J. Control. Release – volume: 11 start-page: 9567 year: 2017 end-page: 9569 ident: b0465 article-title: New Insights into “Permeability” as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics publication-title: ACS Nano – volume: 108 start-page: 1850 year: 2011 end-page: 1855 ident: b1220 article-title: Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo publication-title: Proc. Natl. Acad. Sci. U S A – volume: 13 start-page: 72 year: 2018 end-page: 81 ident: b0840 article-title: Synthetically lethal nanoparticles for treatment of endometrial cancer publication-title: Nat. Nanotechnol. – volume: 115 start-page: 1103 year: 2018 end-page: 1115 ident: b0875 article-title: Extravasation of Brownian Spheroidal Nanoparticles through Vascular Pores publication-title: Biophys. J. – volume: 20 start-page: 1055 year: 2016 end-page: 1073 ident: b0690 article-title: Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment publication-title: Expert Opin Ther Targets – volume: 20 start-page: 49 year: 2021 ident: b1105 article-title: The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors publication-title: Mol Cancer – volume: 15 start-page: 541 year: 2014 end-page: 555 ident: b1340 article-title: Non-viral vectors for gene-based therapy publication-title: Nat. Rev. Genet. – volume: 184 start-page: 3049 year: 2017 end-page: 3067 ident: b0945 article-title: Nanomaterial-based biosensors for detection of prostate specific antigen publication-title: Mikrochim. Acta – volume: 18 start-page: 125 year: 2016 end-page: 158 ident: b1125 article-title: The Lymphatic System in Disease Processes and Cancer Progression publication-title: Annu. Rev. Biomed. Eng. – volume: 12 start-page: 375 year: 2015 end-page: 392 ident: b1320 article-title: Leukocytes as carriers for targeted cancer drug delivery publication-title: Expert Opin Drug Deliv – volume: 88 year: 2020 ident: b0540 article-title: Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors publication-title: Cancer Treat. Rev. – volume: 122 start-page: 931 year: 2020 end-page: 942 ident: b1485 article-title: The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome publication-title: Br. J. Cancer – volume: 8 start-page: 22182 year: 2018 end-page: 22192 ident: b1065 article-title: Manipulating extracellular tumour pH: an effective target for cancer therapy publication-title: RSC Adv. – volume: 1494 start-page: 201 year: 2017 end-page: 213 ident: b0225 article-title: Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines publication-title: Methods Mol. Biol. – volume: 15 start-page: 213 year: 2014 end-page: 222 ident: b0430 article-title: Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy publication-title: AAPS PharmSciTech – volume: 31 start-page: 1296 year: 2014 end-page: 1304 ident: b0750 article-title: Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma publication-title: Oncol. Rep. – volume: 4 start-page: 24 year: 2000 end-page: 29 ident: b1045 article-title: Herceptin: increasing survival in metastatic breast cancer publication-title: Eur. J. Oncol. Nurs. – volume: 34 start-page: 1953 year: 2015 end-page: 1960 ident: b1210 article-title: Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes publication-title: Oncol. Rep. – volume: 516 start-page: 61 year: 2017 end-page: 70 ident: b1270 article-title: Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil publication-title: Int. J. Pharm. – volume: 10 start-page: 1837 year: 2020 ident: b0150 article-title: Study of Structural stability and formation mechanisms in DSPC and DPSM liposomes: A coarse-grained molecular dynamics simulation publication-title: Sci. Rep. – volume: 102 start-page: 13 year: 2020 end-page: 34 ident: b0130 article-title: Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy publication-title: Acta Biomater. – volume: 128 year: 2020 ident: b0650 article-title: Design of integrin alphavbeta3 targeting self-assembled protein nanoparticles with RGD peptide publication-title: Biomed. Pharmacother. – volume: 192 start-page: 209 year: 2014 end-page: 218 ident: b1450 article-title: Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study publication-title: J. Control. Release – volume: 34 start-page: 3617 year: 2015 end-page: 3626 ident: b0035 article-title: Mechanism-based cancer therapy: resistance to therapy, therapy for resistance publication-title: Oncogene – volume: 6 start-page: 286 year: 2015 ident: b0185 article-title: Advances and Challenges of Liposome Assisted Drug Delivery publication-title: Front. Pharmacol. – volume: 32 start-page: 243 year: 2021 end-page: 257 ident: b0315 article-title: An overview of polymeric nanomicelles in clinical trials and on the market publication-title: Chin. Chem. Lett. – volume: 4 start-page: 1928 year: 2018 end-page: 1941 ident: b0290 article-title: Near-Infrared Light-Triggered Polymeric Nanomicelles for Cancer Therapy and Imaging publication-title: ACS Biomater. Sci. Eng. – volume: 82 start-page: 103 year: 2020 end-page: 126 ident: b0330 article-title: The Acidic Tumor Microenvironment as a Driver of Cancer publication-title: Annu. Rev. Physiol. – volume: 70 start-page: 519 year: 2020 end-page: 522 ident: b0025 article-title: Provisional Mortality Data - United States publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 21 start-page: 1327 year: 2020 end-page: 1350 ident: b0355 article-title: Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications publication-title: Biomacromolecules – volume: 105 start-page: 563 year: 2007 end-page: 570 ident: b0630 article-title: Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma publication-title: Gynecol. Oncol. – volume: 12 start-page: 274 year: 2017 end-page: 281 ident: b0990 article-title: Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking publication-title: Nat. Nanotechnol. – volume: 2019 start-page: 1579 year: 1861 end-page: 1591 ident: b1420 article-title: Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models publication-title: Biochim. Biophys. Acta, Biomembr. – volume: 12 start-page: 3369 year: 2012 end-page: 3377 ident: b0870 article-title: Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation publication-title: Nano Lett. – volume: 8 start-page: 275 year: 2012 end-page: 290 ident: b0120 article-title: Iron oxide nanoparticles for targeted cancer imaging and diagnostics publication-title: Nanomedicine – volume: 132 start-page: 171 year: 2008 end-page: 183 ident: b0425 article-title: Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles publication-title: J. Control. Release – volume: 154–155 start-page: 64 year: 2020 end-page: 78 ident: b0180 article-title: Recent advances in siRNA delivery mediated by lipid-based nanoparticles publication-title: Adv. Drug Deliv. Rev. – volume: 13 start-page: 2155 year: 2016 end-page: 2163 ident: b0335 article-title: Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids publication-title: Mol. Pharm. – volume: 16 start-page: 415 year: 2008 end-page: 423 ident: b1240 article-title: Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate publication-title: J. Drug Target. – volume: 12 start-page: 7291 year: 2017 end-page: 7309 ident: b1175 article-title: Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors publication-title: Int. J. Nanomed. – volume: 9 start-page: 1362 year: 2013 end-page: 1369 ident: b0100 article-title: Surface functionalized gold nanoparticles for drug delivery publication-title: J. Biomed. Nanotechnol. – volume: 71 start-page: 209 year: 2021 end-page: 249 ident: b0005 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J. Clin. – volume: 149 start-page: 116 year: 2015 end-page: 128 ident: b1260 article-title: Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines publication-title: J. Photochem. Photobiol., B – volume: 338 start-page: 284 year: 2005 end-page: 293 ident: b0620 article-title: Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay publication-title: Anal. Biochem. – volume: 49 start-page: 112 year: 2008 end-page: 121 ident: b0725 article-title: PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer publication-title: J. Nucl. Med. – volume: 178 start-page: 81 year: 2012 end-page: 88 ident: b0970 article-title: Electrochemical immunosensor for prostate-specific antigen using a glassy carbon electrode modified with a nanocomposite containing gold nanoparticles supported with starch-functionalized multi-walled carbon nanotubes publication-title: Microchim. Acta – volume: 22 year: 2021 ident: b1400 article-title: Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma publication-title: Int. J. Mol. Sci. – volume: 152 start-page: 47 year: 2018 end-page: 62 ident: b1275 article-title: Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer publication-title: Biomaterials – volume: 124 start-page: 880 year: 2021 end-page: 892 ident: b0590 article-title: Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance publication-title: Br. J. Cancer – volume: 139 start-page: 2892 year: 2017 end-page: 2895 ident: b0495 article-title: Selection of 2'-Fluoro-Modified Aptamers with Optimized Properties publication-title: J. Am. Chem. Soc. – volume: 1 start-page: 182 year: 2004 end-page: 188 ident: b0935 article-title: Biomarkers: potential uses and limitations publication-title: NeuroRx – volume: 9 start-page: 2674 year: 2018 end-page: 2689 ident: b1480 article-title: Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy publication-title: Chem. Sci. – volume: 2013 year: 2013 ident: b0720 article-title: F-18 labeled vasoactive intestinal peptide analogue in the PET imaging of colon carcinoma in nude mice publication-title: Biomed. Res. Int. – volume: 381 start-page: 338 year: 2019 end-page: 348 ident: b0600 article-title: Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma publication-title: N. Engl. J. Med. – volume: 52 start-page: 978 year: 2014 end-page: 982 ident: b1250 article-title: Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy publication-title: Pharm. Biol. – volume: 44 start-page: 131 year: 2018 ident: b1410 article-title: Possible strategies to cross the blood-brain barrier publication-title: Ital J Pediatr – volume: 6 start-page: 362 year: 2021 ident: b1470 article-title: Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer publication-title: Sig. Trans. Targeted Ther. – volume: 419 start-page: 33 year: 2016 end-page: 40 ident: b1080 article-title: The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging publication-title: Carbohydr. Res. – volume: 20 start-page: 174 year: 2020 end-page: 186 ident: b1495 article-title: A framework for advancing our understanding of cancer-associated fibroblasts publication-title: Nat. Rev. Cancer – volume: 114 year: 2019 ident: b0685 article-title: Bombesin receptors as potential targets for anticancer drug delivery and imaging publication-title: Int. J. Biochem. Cell Biol. – volume: 17 start-page: 11210 year: 2011 end-page: 11215 ident: b1115 article-title: Simultaneous detection of intracellular tumor mRNA with bi-color imaging based on a gold nanoparticle/molecular beacon publication-title: Chemistry – volume: 18 start-page: 533 year: 2018 end-page: 548 ident: b0640 article-title: Every step of the way: integrins in cancer progression and metastasis publication-title: Nat. Rev. Cancer – volume: 89 start-page: 1 year: 2015 end-page: 8 ident: b0765 article-title: Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis publication-title: Ann. Surg. Treat Res. – volume: 103 start-page: 213 year: 2020 end-page: 222 ident: b0240 article-title: siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery publication-title: Acta Biomater. – volume: 50 start-page: 417 year: 2017 end-page: 427 ident: b0205 article-title: The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response publication-title: Acta Biomater. – volume: 12 start-page: 131 year: 2016 end-page: 141 ident: b1510 article-title: A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts publication-title: Nanomedicine – volume: 130 start-page: 73 year: 2018 end-page: 89 ident: b0405 article-title: Harnessing albumin as a carrier for cancer therapies publication-title: Adv. Drug Deliv. Rev. – volume: 12 start-page: 855 year: 2019 end-page: 861 ident: b1355 article-title: Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer publication-title: Nano Res. – volume: 12 start-page: 1030 year: 2022 end-page: 1060 ident: b0260 article-title: Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies publication-title: Theranostics – volume: 411 start-page: 985 year: 2019 end-page: 995 ident: b1020 article-title: A novel magnetic fluorescent biosensor based on graphene quantum dots for rapid, efficient, and sensitive separation and detection of circulating tumor cells publication-title: Anal. Bioanal. Chem. – volume: 118 start-page: 38 year: 2007 end-page: 53 ident: b1425 article-title: Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle publication-title: J. Control. Release – volume: 140 start-page: 162 year: 2017 end-page: 169 ident: b0410 article-title: Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer publication-title: Biomaterials – volume: 31 start-page: 2147 year: 2020 end-page: 2157 ident: b1455 article-title: Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine publication-title: Bioconjug. Chem. – volume: 6 start-page: 6944 year: 2014 end-page: 6953 ident: b1075 article-title: Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma publication-title: ACS Appl. Mater. Interfaces – volume: 230 year: 2020 ident: b1055 article-title: Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers publication-title: Biomaterials – volume: 596 year: 2021 ident: b1190 article-title: Antibody-mediated drug delivery publication-title: Int. J. Pharm. – volume: 23 start-page: 248 year: 2022 end-page: 258 ident: b0595 article-title: Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study publication-title: Lancet Oncol. – volume: 5 start-page: 11760 year: 2015 ident: b1265 article-title: Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression publication-title: Sci. Rep. – volume: 2 start-page: 904 year: 2014 end-page: 908 ident: b0480 article-title: Passive targeting of nanoparticles to cancer: A comprehensive review of the literature publication-title: Mol Clin Oncol – volume: 22 year: 2019 ident: b0090 article-title: Gold nanoparticle based photothermal therapy: Development and application for effective cancer treatment publication-title: Sustainable Mater.Technol. – volume: 18 year: 2017 ident: b0490 article-title: Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine publication-title: Int. J. Mol. Sci. – volume: 14 start-page: 9693 year: 2019 end-page: 9706 ident: b0530 article-title: Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles publication-title: Int. J. Nanomed. – volume: 19 start-page: 341 year: 2019 ident: b0995 article-title: Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model publication-title: Cancer Cell Int – volume: 6 start-page: 2039 year: 2016 end-page: 2051 ident: b0865 article-title: Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery publication-title: Theranostics – year: 2018 ident: b0475 article-title: Liver—Structure and Microanatomy☆, Reference Module in Biomedical Sciences publication-title: Elsevier – volume: 6 start-page: 201 year: 2021 ident: b1170 article-title: Small molecules in targeted cancer therapy: advances, challenges, and future perspectives publication-title: Signal Transduct Target Ther – volume: 29 start-page: 1905671 year: 2019 ident: b1310 article-title: Cancer Cell Membrane-Coated Nanoparticles for Personalized Therapy in Patient-Derived Xenograft Models publication-title: Adv. Funct. Mater. – volume: 18 start-page: 132 year: 2015 end-page: 143 ident: b1185 article-title: Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis publication-title: Acta Biomater. – volume: 119 start-page: 8698 year: 2015 end-page: 8706 ident: b0165 article-title: Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems publication-title: J. Phys. Chem. B – volume: 1 start-page: 16014 year: 2016 ident: b0800 article-title: Analysis of nanoparticle delivery to tumours publication-title: Nat. Rev. Mater. – volume: 10 start-page: 1606 year: 2020 ident: b0255 article-title: Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells publication-title: Sci. Rep. – volume: 8 start-page: 727 year: 2020 end-page: 735 ident: b0380 article-title: Light-responsive polymersomes with a charge-switch for targeted drug delivery publication-title: J. Mater. Chem. B – volume: 6 start-page: 7607 year: 2012 end-page: 7614 ident: b0980 article-title: Single-step nanoplasmonic VEGF165 aptasensor for early cancer diagnosis publication-title: ACS Nano – volume: 6 start-page: 10095 year: 2014 end-page: 10099 ident: b1535 article-title: Enhanced radiation therapy with internalized polyelectrolyte modified nanoparticles publication-title: Nanoscale – volume: 1 start-page: 193 year: 2005 end-page: 212 ident: b0445 article-title: Role of nanotechnology in targeted drug delivery and imaging: a concise review publication-title: Nanomedicine – volume: 9 year: 2017 ident: b0320 article-title: Dendrimer-based nanocarriers: a versatile platform for drug delivery publication-title: WIREs Nanomed. Nanobiotechnol. – volume: 16 start-page: 2679 year: 2021 end-page: 2693 ident: b0385 article-title: Toward enzyme-responsive polymersome drug delivery publication-title: Nanomedicine (Lond) – volume: 12 year: 2020 ident: b0460 article-title: Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom publication-title: Pharmaceutics – volume: 17 start-page: 595 year: 2020 end-page: 610 ident: b1435 article-title: Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire, Nature Reviews publication-title: Clinical Oncology – volume: 11 start-page: 1042 year: 2014 end-page: 1052 ident: b1295 article-title: RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration publication-title: Mol. Pharm. – volume: 21 start-page: 1399 year: 2017 end-page: 1410 ident: b1395 article-title: Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma publication-title: Cell Rep. – volume: 154 start-page: 24 year: 2018 end-page: 33 ident: b1540 article-title: Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer publication-title: Biomaterials – volume: 20 start-page: 101 year: 2021 end-page: 124 ident: b0075 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discovery – volume: 10 year: 2021 ident: b0570 article-title: Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer publication-title: Cells – reference: R. Smith, E.I. Wafa, S.M. Geary, K. Ebeid, S.O. Alhaj-Suliman, A.K. Salem, Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine, Sci. Adv. 8 (2022) eabk3150. – volume: 15 start-page: 73 year: 2017 end-page: 81 ident: b0910 article-title: Protein Array-based Approaches for Biomarker Discovery in Cancer publication-title: Genom. Proteom. Bioinform. – volume: 6 start-page: 17 year: 2016 ident: b0695 article-title: Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors publication-title: EJNMMI Res – volume: 9 start-page: 1738813 year: 2020 ident: b0885 article-title: Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses publication-title: Oncoimmunology – volume: 22 start-page: 226 year: 2019 end-page: 235 ident: b0815 article-title: Surface modification of pH-responsive poly(2-(tert-butylamino)ethyl methacrylate) brushes grafted on mesoporous silica nanoparticles publication-title: Des. Monomers Polym. – volume: 4 year: 2019 ident: b0275 article-title: Nanoparticles in the clinic: An update publication-title: Bioeng. Transl. Med. – volume: 15 start-page: 353 year: 2018 end-page: 366 ident: b0930 article-title: Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers publication-title: Expert Rev. Proteom. – volume: 18 start-page: 1509 year: 2017 end-page: 1520 ident: b1375 article-title: Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines publication-title: Biomacromolecules – volume: 22 start-page: 3574 year: 2021 end-page: 3589 ident: b1385 article-title: Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders publication-title: Biomacromolecules – volume: 9 year: 2019 ident: b1365 article-title: Cytotoxicity of Dendrimers publication-title: Biomolecules – volume: 101 start-page: 570 year: 2007 end-page: 580 ident: b0645 article-title: Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis publication-title: Circ. Res. – volume: 71 start-page: 1494 year: 2007 end-page: 1499 ident: b0950 article-title: Quantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopy publication-title: Talanta – volume: 26 start-page: 87 year: 2014 end-page: 95 ident: b1130 article-title: Changes in cell and tissue organization in cancer of the breast and colon publication-title: Curr. Opin. Cell Biol. – volume: 33 start-page: 2373 year: 2016 end-page: 2387 ident: b0065 article-title: Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date publication-title: Pharm. Res. – volume: 17 year: 2012 ident: b1155 article-title: Detection of brain tumors using fluorescence diffuse optical tomography and nanoparticles as contrast agents publication-title: J. Biomed. Opt. – volume: 33 start-page: 941 year: 2015 end-page: 951 ident: b0880 article-title: Principles of nanoparticle design for overcoming biological barriers to drug delivery publication-title: Nat. Biotechnol. – volume: 15 start-page: 3843 year: 2020 end-page: 3850 ident: b1545 article-title: Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model publication-title: Int. J. Nanomed. – volume: 8 year: 2019 ident: b0565 article-title: Fibroblast Growth Factor Receptor Signaling in Skin Cancers publication-title: Cells – volume: 17 year: 2016 ident: b0820 article-title: Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses publication-title: Int. J. Mol. Sci. – year: 2021 ident: b0280 article-title: Nanoparticles in the clinic: An update post COVID-19 vaccines publication-title: Bioeng. Transl. Med. – volume: 403 start-page: 285 year: 2011 end-page: 291 ident: b0435 article-title: Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity publication-title: Int. J. Pharm. – volume: 7 start-page: 2301 year: 2011 end-page: 2306 ident: b0535 article-title: Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? publication-title: Small – volume: 26 year: 2015 ident: b1085 article-title: Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI publication-title: Nanotechnology – volume: 179 start-page: 687 year: 2020 end-page: 697 ident: b0545 article-title: Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older publication-title: Breast Cancer Res. Treat. – volume: 987 start-page: 118 year: 2017 end-page: 126 ident: b0965 article-title: Sensitive prostate specific antigen quantification using dihydrolipoic acid surface-functionalized phosphorescent quantum dots publication-title: Anal. Chim. Acta – volume: 24 start-page: 2442 year: 2014 end-page: 2449 ident: b0300 article-title: Dendron-Based Micelles for Topical Delivery of Endoxifen: A Potential Chemo-Preventive Medicine for Breast Cancer publication-title: Adv. Funct. Mater. – volume: 18 start-page: 457 year: 2010 end-page: 467 ident: b0735 article-title: VPAC receptor mediated tumor cell targeting by protamine based nanoparticles publication-title: J. Drug Target. – reference: BEST (Biomarkers, EndpointS, and other Tools) Resource, Silver Spring (MD), 2016. – volume: 49 start-page: 899 year: 2008 end-page: 906 ident: b0635 article-title: Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors publication-title: J. Nucl. Med. – volume: 47 start-page: 1635 year: 2019 end-page: 1641 ident: b1345 article-title: Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA, Artif Cells Nanomed publication-title: Biotechnol – volume: 71 start-page: 7 year: 2021 end-page: 33 ident: b0010 article-title: Cancer Statistics publication-title: CA Cancer J. Clin. – volume: 11 start-page: 20140459 year: 2014 ident: b0155 article-title: Liposomes in tissue engineering and regenerative medicine publication-title: J. R. Soc. Interface – volume: 3 year: 2013 ident: b0740 article-title: Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells publication-title: Drug Deliv Transl Res – volume: 140 start-page: 489 year: 2016 end-page: 496 ident: b1095 article-title: PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging publication-title: Colloids Surf. B Biointerfaces – volume: 92 start-page: 716 year: 2016 end-page: 723 ident: b0520 article-title: EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer publication-title: Int. J. Radiat Biol. – volume: 9 start-page: 3480 year: 2019 ident: b0585 article-title: Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2 publication-title: Sci. Rep. – volume: 18 start-page: 649 year: 2017 end-page: 673 ident: b0350 article-title: Stimuli-Responsive Polymersomes for Biomedical Applications publication-title: Biomacromolecules – volume: 8 start-page: 2000 year: 2014 end-page: 2006 ident: b0760 article-title: A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy publication-title: Oncol. Lett. – volume: 12 start-page: 6973 year: 2017 end-page: 6984 ident: b1280 article-title: Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer publication-title: Int. J. Nanomed. – volume: 26 year: 2021 ident: b1440 article-title: A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers publication-title: Molecules – volume: 118 start-page: 1 year: 2013 end-page: 59 ident: b0775 article-title: Bioengineering strategies for designing targeted cancer therapies publication-title: Adv. Cancer Res. – volume: 2015 year: 2015 ident: b1405 article-title: Blood brain barrier: a challenge for effectual therapy of brain tumors publication-title: Biomed Res. Int. – volume: 296 start-page: F947 year: 2009 end-page: F956 ident: b0470 article-title: Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier publication-title: Am J Physiol Renal Physiol – volume: 383 start-page: 897 year: 2020 end-page: 900 ident: b0015 article-title: Progress in Cancer Research, Prevention, and Care publication-title: N. Engl. J. Med. – volume: 28 start-page: 471 year: 2017 end-page: 480 ident: b0755 article-title: Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization publication-title: Bioconjug. Chem. – volume: 148 year: 2021 ident: b1390 article-title: Advances in development of the dendrimers having natural saccharides in their structure for efficient and controlled drug delivery applications publication-title: Eur. Polym. J. – volume: 136 start-page: 4464 year: 2014 end-page: 4467 ident: b1305 article-title: Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin publication-title: J. Am. Chem. Soc. – volume: 72 start-page: 128 year: 2015 end-page: 144 ident: b0700 article-title: Insights into bombesin receptors and ligands: Highlighting recent advances publication-title: Peptides – volume: 3 start-page: 721 year: 2015 end-page: 732 ident: b1090 article-title: Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors publication-title: Biomater. Sci. – volume: 12 start-page: 813 year: 2017 end-page: 820 ident: b1520 article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers publication-title: Nat. Nanotechnol. – volume: 13 year: 2021 ident: b0175 article-title: Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer Cells publication-title: Pharmaceutics – volume: 96 year: 2017 ident: b0780 article-title: High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer publication-title: Medicine (Baltimore) – volume: 7 start-page: 193 year: 2020 ident: b0095 article-title: Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance publication-title: Front. Mol. Biosci. – volume: 12 start-page: 177 year: 2018 end-page: 190 ident: b0325 article-title: PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy publication-title: Appl. Mater. Today – year: 2018 ident: b0190 article-title: Advances in Biomaterials for Drug Delivery publication-title: Adv. Mater. – volume: 129 start-page: 15477 year: 2007 end-page: 15479 ident: b1110 article-title: Nano-flares: probes for transfection and mRNA detection in living cells publication-title: J. Am. Chem. Soc. – volume: 2 start-page: 21 year: 2018 end-page: 41 ident: b1010 article-title: Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy publication-title: Nanotheranostics – volume: 6 start-page: 27559 year: 2016 ident: b1200 article-title: Core-shell nanocarriers with high paclitaxel loading for passive and active targeting publication-title: Sci. Rep. – volume: 332 start-page: 529 year: 2021 end-page: 538 ident: b0360 article-title: pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects publication-title: J. Control. Release – volume: 157 start-page: 287 year: 2012 end-page: 296 ident: b0525 article-title: EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity publication-title: J. Control. Release – volume: 34 start-page: 3626 year: 2013 end-page: 3638 ident: b0835 article-title: The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer publication-title: Biomaterials – volume: 11 start-page: 46585 year: 2019 end-page: 46590 ident: b1360 article-title: Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid publication-title: ACS Appl. Mater. Interfaces – volume: 21 start-page: 591 year: 2021 ident: b0050 article-title: Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome publication-title: BMC Cancer – volume: 9 start-page: 639 year: 2009 end-page: 651 ident: b0560 article-title: The role of fibroblast growth factors in tumor growth publication-title: Curr. Cancer Drug Targets – volume: 108 start-page: 565 year: 2018 end-page: 573 ident: b0845 article-title: Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer publication-title: Biomed. Pharmacother. – volume: 73 start-page: 38 year: 2018 end-page: 51 ident: b0200 article-title: Customizing poly(lactic-co-glycolic acid) particles for biomedical applications publication-title: Acta Biomater. – volume: 81 start-page: 7009 year: 2009 end-page: 7014 ident: b1050 article-title: Using aptamer-conjugated fluorescence resonance energy transfer nanoparticles for multiplexed cancer cell monitoring publication-title: Anal. Chem. – volume: 10 start-page: 1973 year: 2015 end-page: 1990 ident: b1005 article-title: Nanotechnology for enrichment and detection of circulating tumor cells publication-title: Nanomedicine (Lond) – volume: 121 start-page: 938 year: 2007 end-page: 942 ident: b0615 article-title: Folate receptor overexpression is associated with poor outcome in breast cancer publication-title: Int. J. Cancer – volume: 14 start-page: 823 year: 2020 end-page: 832 ident: b1205 article-title: Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles publication-title: Drug Des. Devel. Ther. – volume: 230 start-page: 259 year: 2015 end-page: 271 ident: b1335 article-title: Gene Therapies for Cancer: Strategies, Challenges and Successes publication-title: J. Cell. Physiol. – volume: 437 start-page: 199 year: 2011 end-page: 213 ident: b0575 article-title: Fibroblast growth factors and their receptors in cancer publication-title: Biochem. J. – volume: 50 start-page: 195 year: 2018 end-page: 203 ident: b0310 article-title: An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) publication-title: Cancer Res Treat – volume: 9 start-page: 978 year: 2018 ident: b0795 article-title: Targeting VEGF/VEGFR to Modulate Antitumor Immunity publication-title: Front. Immunol. – volume: 17 start-page: 862 year: 2017 end-page: 869 ident: b1505 article-title: Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control publication-title: Nano Lett. – volume: 47 start-page: 7029 year: 2008 end-page: 7031 ident: b0390 article-title: Functionalized nanocompartments (synthosomes) with a reduction-triggered release system publication-title: Angew. Chem. Int. Ed. Engl. – volume: 1 start-page: 795 year: 2006 end-page: 805 ident: b0395 article-title: Functionalized nanocompartments (Synthosomes): limitations and prospective applications in industrial biotechnology publication-title: Biotechnol. J. – volume: 17 start-page: 1723 year: 2019 end-page: 1731 ident: b0660 article-title: Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells publication-title: Oncol Lett – volume: 3 start-page: 965 year: 2020 end-page: 977 ident: b0040 article-title: Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design Synthesis, In Vitro, and In Vivo Anticancer Evaluation publication-title: ACS Pharmacol. Transl. Sci. – volume: 27 start-page: 516 year: 2021 end-page: 519 ident: b0055 article-title: Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics publication-title: Trends Mol. Med. – volume: 32 start-page: 2051 year: 2015 end-page: 2059 ident: b0340 article-title: Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways publication-title: Pharm. Res. – volume: 12 year: 2020 ident: b0455 article-title: Protein-Based Nanoparticles as Drug Delivery Systems publication-title: Pharmaceutics – volume: 68 start-page: 111 year: 2018 end-page: 123 ident: b0550 article-title: Clinical development of HER3-targeting monoclonal antibodies: Perils and progress publication-title: Cancer Treat. Rev. – volume: 47 start-page: 8572 year: 2018 end-page: 8610 ident: b0400 article-title: Liposomes and polymersomes: a comparative review towards cell mimicking publication-title: Chem. Soc. Rev. – volume: 9 start-page: 75 year: 2002 end-page: 85 ident: b1040 article-title: The development and clinical use of trastuzumab (Herceptin) publication-title: Endocr. Relat. Cancer – volume: 12 year: 2017 ident: b1165 article-title: The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis publication-title: PLoS ONE – volume: 112 start-page: 809 year: 2015 end-page: 818 ident: b1000 article-title: Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase publication-title: Br. J. Cancer – volume: 31 start-page: 3043 year: 2010 end-page: 3053 ident: b0440 article-title: The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells publication-title: Biomaterials – volume: 11 start-page: 1397 year: 2017 end-page: 1411 ident: b1315 article-title: Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis publication-title: ACS Nano – volume: 13 start-page: 763 year: 2018 end-page: 776 ident: b1215 article-title: Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity publication-title: Int. J. Nanomed. – volume: 2013 year: 2013 ident: b0675 article-title: Peptide receptor targeting in cancer: the somatostatin paradigm publication-title: Int J Pept – volume: 18 start-page: 1862 year: 2021 end-page: 1894 ident: b0415 article-title: The Uniqueness of Albumin as a Carrier in Nanodrug Delivery publication-title: Mol. Pharm. – volume: 38 start-page: 3464 year: 2020 end-page: 3473 ident: b0265 article-title: Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms publication-title: Vaccine – volume: 140 start-page: 8027 year: 2018 end-page: 8036 ident: b0375 article-title: Wavelength-Selective Light-Responsive DASA-Functionalized Polymersome Nanoreactors publication-title: J. Am. Chem. Soc. – volume: 15 start-page: 81 year: 2020 ident: b1060 article-title: Multi-mode biodegradable tumour-microenvironment sensitive nanoparticles for targeted breast cancer imaging publication-title: Nanoscale Res. Lett. – volume: 69 start-page: 363 year: 2019 end-page: 385 ident: b0020 article-title: Cancer treatment and survivorship statistics publication-title: CA Cancer J. Clin. – volume: 91 start-page: 10792 year: 2019 end-page: 10799 ident: b1015 article-title: Aptamer-Functionalized and Gold Nanoparticle Array-Decorated Magnetic Graphene Nanosheets Enable Multiplexed and Sensitive Electrochemical Detection of Rare Circulating Tumor Cells in Whole Blood publication-title: Anal. Chem. – volume: 290 start-page: 1 year: 2018 end-page: 10 ident: b1500 article-title: Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo publication-title: J. Control. Release – volume: 38 start-page: 943 year: 2017 end-page: 953 ident: b1230 article-title: Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin publication-title: Acta Pharmacol. Sin. – volume: 44 start-page: 2963 year: 2015 end-page: 2997 ident: b0915 article-title: Cancer biomarker detection: recent achievements and challenges publication-title: Chem. Soc. Rev. – volume: 5 start-page: 405 year: 2020 end-page: 423 ident: b0250 article-title: Enabling technologies in polymer synthesis: accessing a new design space for advanced polymer materials publication-title: React. Chem. Eng. – volume: 14 start-page: 1106 year: 2014 end-page: 1115 ident: b0850 article-title: Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles publication-title: Macromol. Biosci. – volume: 66 start-page: 11878 year: 2006 end-page: 11887 ident: b1430 article-title: Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration publication-title: Cancer Res. – volume: 9 start-page: 3341 year: 2019 end-page: 3364 ident: b0105 article-title: Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery publication-title: Theranostics – volume: 99 start-page: 28 year: 2016 end-page: 51 ident: b0500 article-title: PEGylation as a strategy for improving nanoparticle-based drug and gene delivery publication-title: Adv. Drug Deliv. Rev. – volume: 38 start-page: 782 year: 2017 end-page: 797 ident: b0060 article-title: Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities publication-title: Acta Pharmacol. Sin. – volume: 354 start-page: 202 year: 2011 end-page: 209 ident: b1235 article-title: Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery publication-title: J. Colloid Interface Sci. – volume: 163–164 start-page: 65 year: 2020 end-page: 83 ident: b0125 article-title: Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies publication-title: Adv. Drug Deliv. Rev. – volume: 71 start-page: 239 year: 2010 end-page: 251 ident: b0710 article-title: Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway publication-title: Curr. Ther. Res. Clin. Exp. – volume: 8 start-page: 1809 year: 2008 end-page: 1818 ident: b0960 article-title: Quantum dot-based protein micro- and nanoarrays for detection of prostate cancer biomarkers publication-title: Proteomics – volume: 2013 year: 2013 ident: b0510 article-title: The role of epidermal growth factor receptor in cancer metastasis and microenvironment publication-title: Biomed Res. Int. – volume: 45 start-page: 1381 year: 2004 end-page: 1389 ident: b0730 article-title: PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog publication-title: J. Nucl. Med. – volume: 3 start-page: 9 year: 2016 ident: b0115 article-title: ZnO Nanoparticles: A Promising Anticancer Agent publication-title: Nanobiomedicine (Rij) – volume: 111 year: 2020 ident: b0245 article-title: Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles publication-title: Mater. Sci. Eng., C – volume: 8 start-page: 916 year: 2018 end-page: 931 ident: b0745 article-title: Transferrin receptor 1 in cancer: a new sight for cancer therapy publication-title: Am. J. Cancer Res. – volume: 22 start-page: 32 year: 2019 end-page: 39 ident: b0220 article-title: Polymeric Particles as Cancer Vaccine Vectors publication-title: Am. Pharm. Rev. – volume: 41 start-page: 120 year: 2008 end-page: 129 ident: b0610 article-title: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases publication-title: Acc. Chem. Res. – volume: 7 start-page: 3827 year: 2017 ident: b0805 article-title: The Effect of shape on Cellular Uptake of Gold Nanoparticles in the forms of Stars Rods, and Triangles publication-title: Sci. Rep. – volume: 9 start-page: 1323 year: 2014 end-page: 1337 ident: b1025 article-title: Near-infrared quantum dots for HER2 localization and imaging of cancer cells publication-title: Int. J. Nanomed. – volume: 332 start-page: 127 year: 2021 end-page: 147 ident: b0295 article-title: Polymeric micelles in cancer therapy: State of the art publication-title: J. Control. Release – volume: 21 year: 2020 ident: b0655 article-title: Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment publication-title: Int. J. Mol. Sci. – volume: 107 start-page: 428 year: 2005 end-page: 448 ident: b1415 article-title: Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery publication-title: J. Control. Release – volume: 606 year: 2021 ident: b0230 article-title: Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF(V600E) melanoma-bearing mice publication-title: Int. J. Pharm. – volume: 29 start-page: 1603239 year: 2017 ident: b0110 article-title: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy publication-title: Adv. Mater. – volume: 8 start-page: 5040 year: 2016 end-page: 5050 ident: b0810 article-title: Surface Modification of Gd Nanoparticles with pH-Responsive Block Copolymers for Use As Smart MRI Contrast Agents publication-title: ACS Appl. Mater. Interfaces – volume: 24 year: 2020 ident: b1325 article-title: Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer publication-title: Nanomedicine – volume: 9 start-page: 8278 year: 2019 ident: b0855 article-title: Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood-brain barrier penetration publication-title: Sci. Rep. – volume: 10 start-page: 26777 year: 2020 end-page: 26791 ident: b0195 article-title: A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems, RSC publication-title: Advances – volume: 31 start-page: 4499 year: 2012 end-page: 4508 ident: b1140 article-title: Interaction of tumor cells and lymphatic vessels in cancer progression publication-title: Oncogene – volume: 42 start-page: 419 year: 2003 end-page: 436 ident: b0905 article-title: Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies publication-title: Clin. Pharmacokinet. – volume: 11 year: 2021 ident: b0925 article-title: FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients publication-title: Front. Oncol. – volume: 46 start-page: 13 year: 2015 end-page: 25 ident: b1350 article-title: Co-delivery of HIF1alpha siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer publication-title: Biomaterials – volume: 3 start-page: 6702 year: 2020 end-page: 6710 ident: b0285 article-title: Laser-Responsive Polymeric Nanomicelles to Subdue Tumor Multidrug Resistance Based on Mild Photodynamic Therapy and Chemotherapy publication-title: ACS Appl. Nano Mater. – volume: 5 start-page: 8710 year: 2011 end-page: 8720 ident: b1160 article-title: Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model publication-title: ACS Nano – volume: 130 start-page: 16778 year: 2008 end-page: 16785 ident: b1460 article-title: Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery publication-title: J. Am. Chem. Soc. – volume: 9 year: 2019 ident: b0420 article-title: Albumin Nanovectors in Cancer Therapy and Imaging publication-title: Biomolecules – volume: 46 start-page: 4218 year: 2017 end-page: 4244 ident: b0070 article-title: Cellular uptake of nanoparticles: journey inside the cell publication-title: Chem. Soc. Rev. – volume: 344 start-page: 1373 year: 2001 end-page: 1377 ident: b0955 article-title: Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate Cancer publication-title: N. Engl. J. Med. – reference: F. Xu, X. Li, X. Huang, J. Pan, Y. Wang, S. Zhou, Development of a pH-responsive polymersome inducing endoplasmic reticulum stress and autophagy blockade, Sci Adv, 6 (2020) eabb8725. – volume: 12 start-page: 5069 year: 2017 end-page: 5085 ident: b1530 article-title: Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells publication-title: Int. J. Nanomed. – volume: 13 year: 2021 ident: b0785 article-title: The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy publication-title: Cancers (Basel) – volume: 20 start-page: 3989 year: 2019 end-page: 4000 ident: b0370 article-title: Temperature-Responsive Polymersomes of Poly(3-methyl-N-vinylcaprolactam)-block-poly(N-vinylpyrrolidone) To Decrease Doxorubicin-Induced Cardiotoxicity publication-title: Biomacromolecules – volume: 9 start-page: 202 year: 2018 ident: b0895 article-title: Poly(Ethylene Glycol)-Polylactide Micelles for Cancer Therapy publication-title: Front. Pharmacol. – volume: 52 start-page: 841 year: 2011 end-page: 844 ident: b0680 article-title: Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment publication-title: J. Nucl. Med. – volume: 3 start-page: 2025 year: 2018 end-page: 2044 ident: b0920 article-title: Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection publication-title: ACS Sens – volume: 4 year: 2021 ident: b0235 article-title: Thiophene derivative-loaded nanoparticles mediate anticancer activity through the inhibition of kinases and microtubule assembly publication-title: Adv Ther (Weinh) – volume: 16 start-page: 71 year: 2018 ident: b0085 article-title: Nano based drug delivery systems: recent developments and future prospects publication-title: J. Nanobiotechnol. – volume: 19 year: 2019 ident: b0555 article-title: Development of a ZHER3-Affibody-Targeted Nano-Vector for Gene Delivery to HER3-Overexpressed Breast Cancer Cells publication-title: Macromol. Biosci. – volume: 20 start-page: 651 year: 2020 end-page: 668 ident: b1445 article-title: A guide to cancer immunotherapy: from T cell basic science to clinical practice publication-title: Nat. Rev. Immunol. – volume: 11 start-page: 5163 year: 2016 end-page: 5185 ident: b0140 article-title: Carbon nanotubes as cancer therapeutic carriers and mediators publication-title: Int. J. Nanomed. – volume: 26 start-page: 83 year: 2008 end-page: 90 ident: b1070 article-title: In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags publication-title: Nat. Biotechnol. – volume: 22 start-page: 949 year: 2011 end-page: 962 ident: b0900 article-title: Targeting of nanoparticles in cancer: drug delivery and diagnostics publication-title: Anticancer Drugs – volume: 13 start-page: 871 year: 2013 end-page: 882 ident: b0790 article-title: VEGF targets the tumour cell publication-title: Nat. Rev. Cancer – reference: J. Park, K.A. Look, Health Care Expenditure Burden of Cancer Care in the United States, Inquiry, 56 (2019) 46958019880696. – volume: 2014 year: 2014 ident: b0515 article-title: Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications publication-title: Mol Biol Int – volume: 21 start-page: 534 year: 2020 end-page: 544 ident: b0270 article-title: Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral Antigens publication-title: Biomacromolecules – volume: 10 start-page: 171 year: 2015 ident: b0135 article-title: Application of functional quantum dot nanoparticles as fluorescence probes in cell labeling and tumor diagnostic imaging publication-title: Nanoscale Res. Lett. – year: 2022 ident: b0860 article-title: Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model publication-title: Bioconjug. Chem. – volume: 112 start-page: 1 year: 2020 end-page: 13 ident: b1330 article-title: Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy publication-title: Acta Biomater. – volume: 23 start-page: 7794 year: 2005 end-page: 7803 ident: b0450 article-title: Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer publication-title: J. Clin. Oncol. – volume: 6 start-page: 3695 year: 2012 end-page: 3702 ident: b1135 article-title: Ag2S quantum dot: a bright and biocompatible fluorescent nanoprobe in the second near-infrared window publication-title: ACS Nano – volume: 49 start-page: 1958 year: 2010 end-page: 1963 ident: b1255 article-title: Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles publication-title: Ind. Eng. Chem. Res. – volume: 43 start-page: 1050 year: 2014 end-page: 1059 ident: b0705 article-title: Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice publication-title: Pancreas – volume: 216 start-page: 347 year: 2008 end-page: 354 ident: b1145 article-title: Tumor lymphangiogenesis and melanoma metastasis publication-title: J. Cell. Physiol. – volume: 4 start-page: 1129 year: 2012 end-page: 1138 ident: b1490 article-title: Cancer-associated fibroblasts as targets for immunotherapy publication-title: Immunotherapy – volume: 14 start-page: 82 year: 2020 end-page: 95 ident: b0580 article-title: FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer publication-title: Cell Adh Migr – volume: 17 start-page: 1355 year: 2018 end-page: 1364 ident: b0045 article-title: Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies publication-title: Mol. Cancer Ther. – volume: 12 start-page: 3119 year: 2015 end-page: 3128 ident: b1150 article-title: Dual-Modality Noninvasive Mapping of Sentinel Lymph Node by Photoacoustic and Near-Infrared Fluorescent Imaging Using Dye-Loaded Mesoporous Silica Nanoparticles publication-title: Mol. Pharm. – volume: 10 year: 2018 ident: b0145 article-title: Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies publication-title: Pharmaceutics – volume: 152 start-page: 418 year: 2011 end-page: 425 ident: b0830 article-title: Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells publication-title: J. Control. Release – volume: 79 start-page: 4798 year: 2007 end-page: 4804 ident: b0975 article-title: Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor publication-title: Anal. Chem. – reference: J. Zhang, Y. Lin, Z. Lin, Q. Wei, J. Qian, R. Ruan, X. Jiang, L. Hou, J. Song, J. Ding, H. Yang, Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy, Adv. Sci. n/a 2103444. – volume: 6 start-page: 37 year: 2017 end-page: 56 ident: b0170 article-title: Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery publication-title: Sustain. Chem. Pharm. – volume: 20 start-page: 9042 year: 2010 end-page: 9046 ident: b1120 article-title: 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging publication-title: J. Mater. Chem. – volume: 495 start-page: 940 year: 2015 end-page: 947 ident: b1380 article-title: Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates publication-title: Int. J. Pharm. – volume: 573 year: 2020 ident: b0345 article-title: Dendrimers in the context of nanomedicine publication-title: Int. J. Pharm. – volume: 11 start-page: 69 year: 2021 ident: b1515 article-title: CAR-T cell therapy: current limitations and potential strategies publication-title: Blood Cancer J. – volume: 158 start-page: 56 year: 2018 end-page: 73 ident: b1285 article-title: Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites publication-title: Biomaterials – volume: 10 start-page: 808 year: 2019 ident: b0305 article-title: PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy publication-title: Front. Pharmacol. – volume: 12 start-page: 76 year: 2019 ident: b1475 article-title: Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications publication-title: J. Hematol. Oncol. – volume: 16 start-page: 15 year: 2012 end-page: 31 ident: b0505 article-title: Targeting the EGFR signaling pathway in cancer therapy publication-title: Expert Opin Ther Targets – volume: 25 year: 2020 ident: b1370 article-title: Applications and Limitations of Dendrimers in Biomedicine publication-title: Molecules – volume: 10 start-page: 69 year: 2011 end-page: 76 ident: b0665 article-title: Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics publication-title: J Lung Cancer – volume: 9 start-page: 8012 year: 2015 end-page: 8021 ident: b1290 article-title: Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis publication-title: ACS Nano – volume: 59 start-page: 1180 year: 2014 end-page: 1191 ident: b0715 article-title: Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat publication-title: Dig. Dis. Sci. – volume: 11 year: 2021 ident: b1300 article-title: Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting publication-title: Nanomaterials (Basel) – volume: 9 start-page: 5123 year: 2015 end-page: 5133 ident: b1195 article-title: Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem publication-title: Drug Des Devel Ther – volume: 107 start-page: 52 year: 2007 end-page: 57 ident: b0625 article-title: Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas publication-title: Gynecol. Oncol. – volume: 11 year: 2019 ident: b1525 article-title: Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy publication-title: Cancers (Basel) – volume: 15 year: 2020 ident: b0605 article-title: INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models publication-title: PLoS ONE – volume: 23 start-page: 1011 year: 2005 end-page: 1027 ident: b0770 article-title: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis publication-title: J. Clin. Oncol. – volume: 35 start-page: 3666 year: 2014 end-page: 3677 ident: b1100 article-title: Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging publication-title: Biomaterials – volume: 12 year: 2021 ident: b0670 article-title: Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy publication-title: Front Endocrinol (Lausanne) – volume: 4 start-page: 22214 year: 2019 end-page: 22227 ident: b1245 article-title: Folic Acid-Functionalized, Condensed Magnetic Nanoparticles for Targeted Delivery of Doxorubicin to Tumor Cancer Cells Overexpressing the Folate Receptor publication-title: ACS Omega – volume: 21 year: 2019 ident: b0215 article-title: Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine publication-title: Nanomedicine – volume: 4 start-page: 143 year: 2013 ident: b0160 article-title: The use of lipid-based nanocarriers for targeted pain therapies publication-title: Front. Pharmacol. – volume: 17 start-page: 2964 year: 2020 end-page: 2973 ident: b0940 article-title: Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review publication-title: Int. J. Med. Sci. – volume: 370 start-page: 855 year: 2019 end-page: 863 ident: b0210 article-title: Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses publication-title: J. Pharmacol. Exp. Ther. – volume: 212 start-page: 167 year: 2004 end-page: 175 ident: b1035 article-title: Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia publication-title: Cancer Lett. – volume: 65 start-page: 36 year: 2013 end-page: 48 ident: b0890 article-title: Liposomal drug delivery systems: from concept to clinical applications publication-title: Adv. Drug Deliv. Rev. – volume: 6 start-page: 249 year: 2021 ident: b0485 article-title: The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives publication-title: Signal Transduct Target Ther – volume: 120 start-page: 169 year: 2007 end-page: 177 ident: b1030 article-title: Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome publication-title: J. Control. Release – volume: 32 start-page: 8010 year: 2011 end-page: 8020 ident: b1225 article-title: Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery publication-title: Biomaterials – volume: 92 start-page: 183 year: 2016 end-page: 193 ident: b1180 article-title: Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy publication-title: Eur. J. Pharm. Sci. – volume: 9 start-page: 3341 year: 2019 ident: 10.1016/j.addr.2022.114482_b0105 article-title: Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery publication-title: Theranostics doi: 10.7150/thno.34576 – volume: 7 start-page: 2301 year: 2011 ident: 10.1016/j.addr.2022.114482_b0535 article-title: Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? publication-title: Small doi: 10.1002/smll.201100628 – volume: 73 start-page: 38 year: 2018 ident: 10.1016/j.addr.2022.114482_b0200 article-title: Customizing poly(lactic-co-glycolic acid) particles for biomedical applications publication-title: Acta Biomater. doi: 10.1016/j.actbio.2018.04.006 – volume: 69 start-page: 363 issue: 2019 year: 2019 ident: 10.1016/j.addr.2022.114482_b0020 article-title: Cancer treatment and survivorship statistics publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21565 – volume: 11 start-page: 1042 year: 2014 ident: 10.1016/j.addr.2022.114482_b1295 article-title: RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration publication-title: Mol. Pharm. doi: 10.1021/mp400751g – volume: 19 year: 2019 ident: 10.1016/j.addr.2022.114482_b0555 article-title: Development of a ZHER3-Affibody-Targeted Nano-Vector for Gene Delivery to HER3-Overexpressed Breast Cancer Cells publication-title: Macromol. Biosci. doi: 10.1002/mabi.201900159 – volume: 23 start-page: 1011 year: 2005 ident: 10.1016/j.addr.2022.114482_b0770 article-title: Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.06.081 – volume: 3 start-page: 6702 year: 2020 ident: 10.1016/j.addr.2022.114482_b0285 article-title: Laser-Responsive Polymeric Nanomicelles to Subdue Tumor Multidrug Resistance Based on Mild Photodynamic Therapy and Chemotherapy publication-title: ACS Appl. Nano Mater. doi: 10.1021/acsanm.0c01148 – volume: 516 start-page: 61 year: 2017 ident: 10.1016/j.addr.2022.114482_b1270 article-title: Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2016.11.012 – volume: 49 start-page: 899 year: 2008 ident: 10.1016/j.addr.2022.114482_b0635 article-title: Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors publication-title: J. Nucl. Med. doi: 10.2967/jnumed.107.049478 – volume: 987 start-page: 118 year: 2017 ident: 10.1016/j.addr.2022.114482_b0965 article-title: Sensitive prostate specific antigen quantification using dihydrolipoic acid surface-functionalized phosphorescent quantum dots publication-title: Anal. Chim. Acta doi: 10.1016/j.aca.2017.08.003 – volume: 140 start-page: 489 year: 2016 ident: 10.1016/j.addr.2022.114482_b1095 article-title: PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging publication-title: Colloids Surf. B Biointerfaces doi: 10.1016/j.colsurfb.2016.01.019 – volume: 3 start-page: 9 year: 2016 ident: 10.1016/j.addr.2022.114482_b0115 article-title: ZnO Nanoparticles: A Promising Anticancer Agent publication-title: Nanobiomedicine (Rij) doi: 10.5772/63437 – volume: 11 start-page: 5163 year: 2016 ident: 10.1016/j.addr.2022.114482_b0140 article-title: Carbon nanotubes as cancer therapeutic carriers and mediators publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S112660 – volume: 2 start-page: 904 year: 2014 ident: 10.1016/j.addr.2022.114482_b0480 article-title: Passive targeting of nanoparticles to cancer: A comprehensive review of the literature publication-title: Mol Clin Oncol doi: 10.3892/mco.2014.356 – volume: 6 start-page: 201 year: 2021 ident: 10.1016/j.addr.2022.114482_b1170 article-title: Small molecules in targeted cancer therapy: advances, challenges, and future perspectives publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00572-w – volume: 6 start-page: 37 year: 2017 ident: 10.1016/j.addr.2022.114482_b0170 article-title: Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery publication-title: Sustain. Chem. Pharm. doi: 10.1016/j.scp.2017.07.002 – volume: 132 start-page: 171 year: 2008 ident: 10.1016/j.addr.2022.114482_b0425 article-title: Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles publication-title: J. Control. Release doi: 10.1016/j.jconrel.2008.05.010 – volume: 140 start-page: 8027 year: 2018 ident: 10.1016/j.addr.2022.114482_b0375 article-title: Wavelength-Selective Light-Responsive DASA-Functionalized Polymersome Nanoreactors publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.8b04511 – volume: 5 start-page: 8710 year: 2011 ident: 10.1016/j.addr.2022.114482_b1160 article-title: Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model publication-title: ACS Nano doi: 10.1021/nn2026353 – ident: 10.1016/j.addr.2022.114482_b0365 doi: 10.1126/sciadv.abb8725 – volume: 370 start-page: 855 year: 2019 ident: 10.1016/j.addr.2022.114482_b0210 article-title: Single Dose of a Polyanhydride Particle-Based Vaccine Generates Potent Antigen-Specific Antitumor Immune Responses publication-title: J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.118.252809 – volume: 52 start-page: 841 year: 2011 ident: 10.1016/j.addr.2022.114482_b0680 article-title: Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment publication-title: J. Nucl. Med. doi: 10.2967/jnumed.110.084236 – volume: 11 start-page: 69 year: 2021 ident: 10.1016/j.addr.2022.114482_b1515 article-title: CAR-T cell therapy: current limitations and potential strategies publication-title: Blood Cancer J. doi: 10.1038/s41408-021-00459-7 – volume: 2014 year: 2014 ident: 10.1016/j.addr.2022.114482_b0515 article-title: Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications publication-title: Mol Biol Int doi: 10.1155/2014/852748 – volume: 606 year: 2021 ident: 10.1016/j.addr.2022.114482_b0230 article-title: Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF(V600E) melanoma-bearing mice publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120876 – ident: 10.1016/j.addr.2022.114482_b0825 doi: 10.1002/advs.202103444 – volume: 38 start-page: 782 year: 2017 ident: 10.1016/j.addr.2022.114482_b0060 article-title: Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2017.34 – volume: 11 year: 2019 ident: 10.1016/j.addr.2022.114482_b1525 article-title: Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy publication-title: Cancers (Basel) doi: 10.3390/cancers11111783 – year: 2018 ident: 10.1016/j.addr.2022.114482_b0475 article-title: Liver—Structure and Microanatomy☆, Reference Module in Biomedical Sciences publication-title: Elsevier – volume: 9 start-page: 978 year: 2018 ident: 10.1016/j.addr.2022.114482_b0795 article-title: Targeting VEGF/VEGFR to Modulate Antitumor Immunity publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.00978 – volume: 403 start-page: 285 year: 2011 ident: 10.1016/j.addr.2022.114482_b0435 article-title: Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.10.041 – volume: 31 start-page: 2147 year: 2020 ident: 10.1016/j.addr.2022.114482_b1455 article-title: Biotinylated Streptavidin Surface Coating Improves the Efficacy of a PLGA Microparticle-Based Cancer Vaccine publication-title: Bioconjug. Chem. doi: 10.1021/acs.bioconjchem.0c00347 – volume: 9 year: 2019 ident: 10.1016/j.addr.2022.114482_b0420 article-title: Albumin Nanovectors in Cancer Therapy and Imaging publication-title: Biomolecules doi: 10.3390/biom9060218 – volume: 124 start-page: 880 year: 2021 ident: 10.1016/j.addr.2022.114482_b0590 article-title: Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance publication-title: Br. J. Cancer doi: 10.1038/s41416-020-01157-0 – volume: 179 start-page: 687 year: 2020 ident: 10.1016/j.addr.2022.114482_b0545 article-title: Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-019-05505-4 – volume: 9 year: 2019 ident: 10.1016/j.addr.2022.114482_b1365 article-title: Cytotoxicity of Dendrimers publication-title: Biomolecules doi: 10.3390/biom9080330 – volume: 17 year: 2016 ident: 10.1016/j.addr.2022.114482_b0820 article-title: Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms17091440 – volume: 163–164 start-page: 65 year: 2020 ident: 10.1016/j.addr.2022.114482_b0125 article-title: Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2020.06.025 – volume: 354 start-page: 202 year: 2011 ident: 10.1016/j.addr.2022.114482_b1235 article-title: Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery publication-title: J. Colloid Interface Sci. doi: 10.1016/j.jcis.2010.10.054 – volume: 114 year: 2019 ident: 10.1016/j.addr.2022.114482_b0685 article-title: Bombesin receptors as potential targets for anticancer drug delivery and imaging publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2019.105567 – volume: 47 start-page: 1635 year: 2019 ident: 10.1016/j.addr.2022.114482_b1345 article-title: Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA, Artif Cells Nanomed publication-title: Biotechnol – volume: 112 start-page: 1 year: 2020 ident: 10.1016/j.addr.2022.114482_b1330 article-title: Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy publication-title: Acta Biomater. doi: 10.1016/j.actbio.2020.05.028 – volume: 3 start-page: 2025 year: 2018 ident: 10.1016/j.addr.2022.114482_b0920 article-title: Stress Biomarkers in Biological Fluids and Their Point-of-Use Detection publication-title: ACS Sens doi: 10.1021/acssensors.8b00726 – volume: 21 year: 2020 ident: 10.1016/j.addr.2022.114482_b0655 article-title: Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21176018 – volume: 118 start-page: 38 year: 2007 ident: 10.1016/j.addr.2022.114482_b1425 article-title: Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle publication-title: J. Control. Release doi: 10.1016/j.jconrel.2006.11.015 – volume: 148 year: 2021 ident: 10.1016/j.addr.2022.114482_b1390 article-title: Advances in development of the dendrimers having natural saccharides in their structure for efficient and controlled drug delivery applications publication-title: Eur. Polym. J. doi: 10.1016/j.eurpolymj.2021.110356 – volume: 6 start-page: 6944 year: 2014 ident: 10.1016/j.addr.2022.114482_b1075 article-title: Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/am500761x – volume: 495 start-page: 940 year: 2015 ident: 10.1016/j.addr.2022.114482_b1380 article-title: Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2015.09.065 – volume: 108 start-page: 1850 year: 2011 ident: 10.1016/j.addr.2022.114482_b1220 article-title: Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo publication-title: Proc. Natl. Acad. Sci. U S A doi: 10.1073/pnas.1011379108 – volume: 11 start-page: 9567 year: 2017 ident: 10.1016/j.addr.2022.114482_b0465 article-title: New Insights into “Permeability” as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics publication-title: ACS Nano doi: 10.1021/acsnano.7b07214 – volume: 22 start-page: 226 year: 2019 ident: 10.1016/j.addr.2022.114482_b0815 article-title: Surface modification of pH-responsive poly(2-(tert-butylamino)ethyl methacrylate) brushes grafted on mesoporous silica nanoparticles publication-title: Des. Monomers Polym. doi: 10.1080/15685551.2019.1699727 – volume: 157 start-page: 287 year: 2012 ident: 10.1016/j.addr.2022.114482_b0525 article-title: EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity publication-title: J. Control. Release doi: 10.1016/j.jconrel.2011.08.015 – volume: 152 start-page: 418 year: 2011 ident: 10.1016/j.addr.2022.114482_b0830 article-title: Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells publication-title: J. Control. Release doi: 10.1016/j.jconrel.2011.03.017 – volume: 33 start-page: 941 year: 2015 ident: 10.1016/j.addr.2022.114482_b0880 article-title: Principles of nanoparticle design for overcoming biological barriers to drug delivery publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3330 – volume: 71 start-page: 239 year: 2010 ident: 10.1016/j.addr.2022.114482_b0710 article-title: Effects of lorglumide on growth and invasion of human pancreatic cancer cell line Mia PaCa-2 in vitro through the cholecystokinin-cholecystokinin-1 receptor pathway publication-title: Curr. Ther. Res. Clin. Exp. doi: 10.1016/j.curtheres.2010.08.005 – volume: 92 start-page: 716 year: 2016 ident: 10.1016/j.addr.2022.114482_b0520 article-title: EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer publication-title: Int. J. Radiat Biol. doi: 10.3109/09553002.2016.1145360 – volume: 26 year: 2021 ident: 10.1016/j.addr.2022.114482_b1440 article-title: A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers publication-title: Molecules doi: 10.3390/molecules26113382 – volume: 4 start-page: 1928 year: 2018 ident: 10.1016/j.addr.2022.114482_b0290 article-title: Near-Infrared Light-Triggered Polymeric Nanomicelles for Cancer Therapy and Imaging publication-title: ACS Biomater. Sci. Eng. doi: 10.1021/acsbiomaterials.7b00648 – volume: 212 start-page: 167 year: 2004 ident: 10.1016/j.addr.2022.114482_b1035 article-title: Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia publication-title: Cancer Lett. doi: 10.1016/j.canlet.2004.03.038 – volume: 1 start-page: 795 year: 2006 ident: 10.1016/j.addr.2022.114482_b0395 article-title: Functionalized nanocompartments (Synthosomes): limitations and prospective applications in industrial biotechnology publication-title: Biotechnol. J. doi: 10.1002/biot.200600050 – volume: 437 start-page: 199 year: 2011 ident: 10.1016/j.addr.2022.114482_b0575 article-title: Fibroblast growth factors and their receptors in cancer publication-title: Biochem. J. doi: 10.1042/BJ20101603 – volume: 6 start-page: 17 year: 2016 ident: 10.1016/j.addr.2022.114482_b0695 article-title: Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors publication-title: EJNMMI Res doi: 10.1186/s13550-016-0175-x – volume: 10 start-page: 1973 year: 2015 ident: 10.1016/j.addr.2022.114482_b1005 article-title: Nanotechnology for enrichment and detection of circulating tumor cells publication-title: Nanomedicine (Lond) doi: 10.2217/nnm.15.32 – volume: 49 start-page: 1958 year: 2010 ident: 10.1016/j.addr.2022.114482_b1255 article-title: Folate-Receptor-Targeted Delivery of Doxorubicin Using Polyethylene Glycol-Functionalized Gold Nanoparticles publication-title: Ind. Eng. Chem. Res. doi: 10.1021/ie9011479 – volume: 12 start-page: 375 year: 2015 ident: 10.1016/j.addr.2022.114482_b1320 article-title: Leukocytes as carriers for targeted cancer drug delivery publication-title: Expert Opin Drug Deliv doi: 10.1517/17425247.2015.966684 – volume: 1494 start-page: 201 year: 2017 ident: 10.1016/j.addr.2022.114482_b0225 article-title: Production of Adjuvant-Loaded Biodegradable Particles for Use in Cancer Vaccines publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-6445-1_14 – volume: 108 start-page: 565 year: 2018 ident: 10.1016/j.addr.2022.114482_b0845 article-title: Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2018.09.039 – volume: 2015 year: 2015 ident: 10.1016/j.addr.2022.114482_b1405 article-title: Blood brain barrier: a challenge for effectual therapy of brain tumors publication-title: Biomed Res. Int. doi: 10.1155/2015/320941 – volume: 596 year: 2021 ident: 10.1016/j.addr.2022.114482_b1190 article-title: Antibody-mediated drug delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2021.120268 – volume: 13 year: 2021 ident: 10.1016/j.addr.2022.114482_b0785 article-title: The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy publication-title: Cancers (Basel) doi: 10.3390/cancers13051072 – volume: 158 start-page: 56 year: 2018 ident: 10.1016/j.addr.2022.114482_b1285 article-title: Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.12.018 – volume: 10 year: 2018 ident: 10.1016/j.addr.2022.114482_b0145 article-title: Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies publication-title: Pharmaceutics doi: 10.3390/pharmaceutics10030151 – volume: 4 year: 2021 ident: 10.1016/j.addr.2022.114482_b0235 article-title: Thiophene derivative-loaded nanoparticles mediate anticancer activity through the inhibition of kinases and microtubule assembly publication-title: Adv Ther (Weinh) – volume: 68 start-page: 111 year: 2018 ident: 10.1016/j.addr.2022.114482_b0550 article-title: Clinical development of HER3-targeting monoclonal antibodies: Perils and progress publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2018.06.011 – volume: 6 start-page: 362 year: 2021 ident: 10.1016/j.addr.2022.114482_b1470 article-title: Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer publication-title: Sig. Trans. Targeted Ther. doi: 10.1038/s41392-021-00670-9 – volume: 6 start-page: 249 year: 2021 ident: 10.1016/j.addr.2022.114482_b0485 article-title: The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00659-4 – volume: 18 start-page: 132 year: 2015 ident: 10.1016/j.addr.2022.114482_b1185 article-title: Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis publication-title: Acta Biomater. doi: 10.1016/j.actbio.2015.02.022 – volume: 111 year: 2020 ident: 10.1016/j.addr.2022.114482_b0245 article-title: Microfluidic-assisted polymer-protein assembly to fabricate homogeneous functionalnanoparticles publication-title: Mater. Sci. Eng., C doi: 10.1016/j.msec.2020.110768 – volume: 16 start-page: 2679 year: 2021 ident: 10.1016/j.addr.2022.114482_b0385 article-title: Toward enzyme-responsive polymersome drug delivery publication-title: Nanomedicine (Lond) doi: 10.2217/nnm-2021-0194 – volume: 154 start-page: 24 year: 2018 ident: 10.1016/j.addr.2022.114482_b1540 article-title: Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.10.048 – volume: 21 start-page: 591 year: 2021 ident: 10.1016/j.addr.2022.114482_b0050 article-title: Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome publication-title: BMC Cancer doi: 10.1186/s12885-021-08296-4 – volume: 21 year: 2019 ident: 10.1016/j.addr.2022.114482_b0215 article-title: Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine publication-title: Nanomedicine – volume: 10 start-page: 808 year: 2019 ident: 10.1016/j.addr.2022.114482_b0305 article-title: PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy publication-title: Front. Pharmacol. doi: 10.3389/fphar.2019.00808 – volume: 66 start-page: 11878 year: 2006 ident: 10.1016/j.addr.2022.114482_b1430 article-title: Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-06-2354 – volume: 12 start-page: 813 year: 2017 ident: 10.1016/j.addr.2022.114482_b1520 article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2017.57 – volume: 14 start-page: 82 year: 2020 ident: 10.1016/j.addr.2022.114482_b0580 article-title: FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer publication-title: Cell Adh Migr doi: 10.1080/19336918.2020.1766308 – volume: 22 year: 2019 ident: 10.1016/j.addr.2022.114482_b0090 article-title: Gold nanoparticle based photothermal therapy: Development and application for effective cancer treatment publication-title: Sustainable Mater.Technol. – volume: 8 year: 2019 ident: 10.1016/j.addr.2022.114482_b0565 article-title: Fibroblast Growth Factor Receptor Signaling in Skin Cancers publication-title: Cells doi: 10.3390/cells8060540 – volume: 79 start-page: 4798 year: 2007 ident: 10.1016/j.addr.2022.114482_b0975 article-title: Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor publication-title: Anal. Chem. doi: 10.1021/ac0707075 – volume: 71 start-page: 1494 year: 2007 ident: 10.1016/j.addr.2022.114482_b0950 article-title: Quantum dot-based immunosensor for the detection of prostate-specific antigen using fluorescence microscopy publication-title: Talanta doi: 10.1016/j.talanta.2006.07.027 – volume: 2 start-page: 21 year: 2018 ident: 10.1016/j.addr.2022.114482_b1010 article-title: Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy publication-title: Nanotheranostics doi: 10.7150/ntno.22091 – volume: 230 year: 2020 ident: 10.1016/j.addr.2022.114482_b1055 article-title: Optical imaging and pH-awakening therapy of deep tissue cancer based on specific upconversion nanophotosensitizers publication-title: Biomaterials doi: 10.1016/j.biomaterials.2019.119637 – volume: 10 start-page: 69 year: 2011 ident: 10.1016/j.addr.2022.114482_b0665 article-title: Somatostatin Receptors in Lung Cancer: From Function to Molecular Imaging and Therapeutics publication-title: J Lung Cancer doi: 10.6058/jlc.2011.10.2.69 – volume: 20 start-page: 174 year: 2020 ident: 10.1016/j.addr.2022.114482_b1495 article-title: A framework for advancing our understanding of cancer-associated fibroblasts publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0238-1 – volume: 10 year: 2021 ident: 10.1016/j.addr.2022.114482_b0570 article-title: Targeting the Fibroblast Growth Factor Receptor (FGFR) Family in Lung Cancer publication-title: Cells doi: 10.3390/cells10051154 – volume: 18 start-page: 533 year: 2018 ident: 10.1016/j.addr.2022.114482_b0640 article-title: Every step of the way: integrins in cancer progression and metastasis publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-018-0038-z – volume: 31 start-page: 3043 year: 2010 ident: 10.1016/j.addr.2022.114482_b0440 article-title: The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2010.01.009 – volume: 35 start-page: 3666 year: 2014 ident: 10.1016/j.addr.2022.114482_b1100 article-title: Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.01.011 – volume: 9 start-page: 5123 year: 2015 ident: 10.1016/j.addr.2022.114482_b1195 article-title: Novel synthesizing method of pH-dependent doxorubicin-loaded anti-CD22-labelled drug delivery nanosystem publication-title: Drug Des Devel Ther doi: 10.2147/DDDT.S86764 – volume: 9 start-page: 2674 year: 2018 ident: 10.1016/j.addr.2022.114482_b1480 article-title: Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy publication-title: Chem. Sci. doi: 10.1039/C7SC04853J – volume: 8 start-page: 275 year: 2012 ident: 10.1016/j.addr.2022.114482_b0120 article-title: Iron oxide nanoparticles for targeted cancer imaging and diagnostics publication-title: Nanomedicine doi: 10.1016/j.nano.2011.08.017 – volume: 10 start-page: 171 year: 2015 ident: 10.1016/j.addr.2022.114482_b0135 article-title: Application of functional quantum dot nanoparticles as fluorescence probes in cell labeling and tumor diagnostic imaging publication-title: Nanoscale Res. Lett. doi: 10.1186/s11671-015-0873-8 – volume: 10 start-page: 1837 year: 2020 ident: 10.1016/j.addr.2022.114482_b0150 article-title: Study of Structural stability and formation mechanisms in DSPC and DPSM liposomes: A coarse-grained molecular dynamics simulation publication-title: Sci. Rep. doi: 10.1038/s41598-020-58730-z – volume: 20 start-page: 49 year: 2021 ident: 10.1016/j.addr.2022.114482_b1105 article-title: The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors publication-title: Mol Cancer doi: 10.1186/s12943-021-01341-7 – volume: 4 start-page: 22214 year: 2019 ident: 10.1016/j.addr.2022.114482_b1245 article-title: Folic Acid-Functionalized, Condensed Magnetic Nanoparticles for Targeted Delivery of Doxorubicin to Tumor Cancer Cells Overexpressing the Folate Receptor publication-title: ACS Omega doi: 10.1021/acsomega.9b03594 – volume: 20 start-page: 101 year: 2021 ident: 10.1016/j.addr.2022.114482_b0075 article-title: Engineering precision nanoparticles for drug delivery publication-title: Nat. Rev. Drug Discovery doi: 10.1038/s41573-020-0090-8 – volume: 46 start-page: 4218 year: 2017 ident: 10.1016/j.addr.2022.114482_b0070 article-title: Cellular uptake of nanoparticles: journey inside the cell publication-title: Chem. Soc. Rev. doi: 10.1039/C6CS00636A – ident: 10.1016/j.addr.2022.114482_b0985 – volume: 12 start-page: 131 year: 2016 ident: 10.1016/j.addr.2022.114482_b1510 article-title: A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts publication-title: Nanomedicine doi: 10.1016/j.nano.2015.10.001 – volume: 105 start-page: 563 year: 2007 ident: 10.1016/j.addr.2022.114482_b0630 article-title: Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2006.10.063 – volume: 31 start-page: 1296 year: 2014 ident: 10.1016/j.addr.2022.114482_b0750 article-title: Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma publication-title: Oncol. Rep. doi: 10.3892/or.2014.2981 – volume: 20 start-page: 651 year: 2020 ident: 10.1016/j.addr.2022.114482_b1445 article-title: A guide to cancer immunotherapy: from T cell basic science to clinical practice publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-020-0306-5 – volume: 18 start-page: 125 year: 2016 ident: 10.1016/j.addr.2022.114482_b1125 article-title: The Lymphatic System in Disease Processes and Cancer Progression publication-title: Annu. Rev. Biomed. Eng. doi: 10.1146/annurev-bioeng-112315-031200 – volume: 16 start-page: 415 year: 2008 ident: 10.1016/j.addr.2022.114482_b1240 article-title: Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate publication-title: J. Drug Target. doi: 10.1080/10611860802088630 – volume: 17 start-page: 2964 year: 2020 ident: 10.1016/j.addr.2022.114482_b0940 article-title: Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review publication-title: Int. J. Med. Sci. doi: 10.7150/ijms.49801 – volume: 296 start-page: F947 year: 2009 ident: 10.1016/j.addr.2022.114482_b0470 article-title: Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.90601.2008 – volume: 119 start-page: 8698 year: 2015 ident: 10.1016/j.addr.2022.114482_b0165 article-title: Microfluidic Mixing: A General Method for Encapsulating Macromolecules in Lipid Nanoparticle Systems publication-title: J. Phys. Chem. B doi: 10.1021/acs.jpcb.5b02891 – volume: 15 year: 2020 ident: 10.1016/j.addr.2022.114482_b0605 article-title: INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models publication-title: PLoS ONE – volume: 17 start-page: 11210 year: 2011 ident: 10.1016/j.addr.2022.114482_b1115 article-title: Simultaneous detection of intracellular tumor mRNA with bi-color imaging based on a gold nanoparticle/molecular beacon publication-title: Chemistry doi: 10.1002/chem.201100658 – volume: 107 start-page: 428 year: 2005 ident: 10.1016/j.addr.2022.114482_b1415 article-title: Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.03.027 – volume: 115 start-page: 1103 year: 2018 ident: 10.1016/j.addr.2022.114482_b0875 article-title: Extravasation of Brownian Spheroidal Nanoparticles through Vascular Pores publication-title: Biophys. J. doi: 10.1016/j.bpj.2018.07.038 – volume: 70 start-page: 519 issue: 2021 year: 2020 ident: 10.1016/j.addr.2022.114482_b0025 article-title: Provisional Mortality Data - United States publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 6 start-page: 286 year: 2015 ident: 10.1016/j.addr.2022.114482_b0185 article-title: Advances and Challenges of Liposome Assisted Drug Delivery publication-title: Front. Pharmacol. doi: 10.3389/fphar.2015.00286 – volume: 65 start-page: 36 year: 2013 ident: 10.1016/j.addr.2022.114482_b0890 article-title: Liposomal drug delivery systems: from concept to clinical applications publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2012.09.037 – volume: 332 start-page: 529 year: 2021 ident: 10.1016/j.addr.2022.114482_b0360 article-title: pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects publication-title: J. Control. Release doi: 10.1016/j.jconrel.2021.03.013 – volume: 8 start-page: 916 year: 2018 ident: 10.1016/j.addr.2022.114482_b0745 article-title: Transferrin receptor 1 in cancer: a new sight for cancer therapy publication-title: Am. J. Cancer Res. – volume: 26 start-page: 83 year: 2008 ident: 10.1016/j.addr.2022.114482_b1070 article-title: In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags publication-title: Nat. Biotechnol. doi: 10.1038/nbt1377 – volume: 33 start-page: 2373 year: 2016 ident: 10.1016/j.addr.2022.114482_b0065 article-title: Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date publication-title: Pharm. Res. doi: 10.1007/s11095-016-1958-5 – volume: 21 start-page: 1399 year: 2017 ident: 10.1016/j.addr.2022.114482_b1395 article-title: Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.10.030 – volume: 17 year: 2012 ident: 10.1016/j.addr.2022.114482_b1155 article-title: Detection of brain tumors using fluorescence diffuse optical tomography and nanoparticles as contrast agents publication-title: J. Biomed. Opt. doi: 10.1117/1.JBO.17.12.126004 – volume: 25 year: 2020 ident: 10.1016/j.addr.2022.114482_b1370 article-title: Applications and Limitations of Dendrimers in Biomedicine publication-title: Molecules doi: 10.3390/molecules25173982 – volume: 246 start-page: 183 year: 2017 ident: 10.1016/j.addr.2022.114482_b0080 article-title: Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond publication-title: J. Control. Release doi: 10.1016/j.jconrel.2017.01.011 – volume: 12 start-page: 6973 year: 2017 ident: 10.1016/j.addr.2022.114482_b1280 article-title: Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S139011 – volume: 4 year: 2019 ident: 10.1016/j.addr.2022.114482_b0275 article-title: Nanoparticles in the clinic: An update publication-title: Bioeng. Transl. Med. doi: 10.1002/btm2.10143 – volume: 8 start-page: 22182 year: 2018 ident: 10.1016/j.addr.2022.114482_b1065 article-title: Manipulating extracellular tumour pH: an effective target for cancer therapy publication-title: RSC Adv. doi: 10.1039/C8RA02095G – volume: 12 start-page: 274 year: 2017 ident: 10.1016/j.addr.2022.114482_b0990 article-title: Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2016.239 – volume: 18 start-page: 1509 year: 2017 ident: 10.1016/j.addr.2022.114482_b1375 article-title: Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines publication-title: Biomacromolecules doi: 10.1021/acs.biomac.7b00046 – volume: 20 start-page: 1055 year: 2016 ident: 10.1016/j.addr.2022.114482_b0690 article-title: Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2016.1164694 – volume: 1 start-page: 182 year: 2004 ident: 10.1016/j.addr.2022.114482_b0935 article-title: Biomarkers: potential uses and limitations publication-title: NeuroRx doi: 10.1602/neurorx.1.2.182 – volume: 29 start-page: 1905671 year: 2019 ident: 10.1016/j.addr.2022.114482_b1310 article-title: Cancer Cell Membrane-Coated Nanoparticles for Personalized Therapy in Patient-Derived Xenograft Models publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201905671 – volume: 13 start-page: 871 year: 2013 ident: 10.1016/j.addr.2022.114482_b0790 article-title: VEGF targets the tumour cell publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3627 – volume: 32 start-page: 8010 year: 2011 ident: 10.1016/j.addr.2022.114482_b1225 article-title: Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.07.004 – volume: 41 start-page: 120 year: 2008 ident: 10.1016/j.addr.2022.114482_b0610 article-title: Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases publication-title: Acc. Chem. Res. doi: 10.1021/ar7000815 – volume: 2013 year: 2013 ident: 10.1016/j.addr.2022.114482_b0675 article-title: Peptide receptor targeting in cancer: the somatostatin paradigm publication-title: Int J Pept doi: 10.1155/2013/926295 – volume: 71 start-page: 7 issue: 2021 year: 2021 ident: 10.1016/j.addr.2022.114482_b0010 article-title: Cancer Statistics publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21654 – volume: 27 start-page: 516 year: 2021 ident: 10.1016/j.addr.2022.114482_b0055 article-title: Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2021.04.002 – volume: 22 start-page: 949 year: 2011 ident: 10.1016/j.addr.2022.114482_b0900 article-title: Targeting of nanoparticles in cancer: drug delivery and diagnostics publication-title: Anticancer Drugs doi: 10.1097/CAD.0b013e32834a4554 – volume: 149 start-page: 116 year: 2015 ident: 10.1016/j.addr.2022.114482_b1260 article-title: Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines publication-title: J. Photochem. Photobiol., B doi: 10.1016/j.jphotobiol.2015.05.008 – volume: 12 year: 2021 ident: 10.1016/j.addr.2022.114482_b0670 article-title: Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2021.679000 – volume: 50 start-page: 195 year: 2018 ident: 10.1016/j.addr.2022.114482_b0310 article-title: An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021) publication-title: Cancer Res Treat doi: 10.4143/crt.2016.376 – volume: 11 start-page: 1397 year: 2017 ident: 10.1016/j.addr.2022.114482_b1315 article-title: Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis publication-title: ACS Nano doi: 10.1021/acsnano.6b06477 – volume: 1 start-page: 193 year: 2005 ident: 10.1016/j.addr.2022.114482_b0445 article-title: Role of nanotechnology in targeted drug delivery and imaging: a concise review publication-title: Nanomedicine doi: 10.1016/j.nano.2005.06.004 – volume: 38 start-page: 943 year: 2017 ident: 10.1016/j.addr.2022.114482_b1230 article-title: Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2017.45 – volume: 18 year: 2017 ident: 10.1016/j.addr.2022.114482_b0490 article-title: Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms18102142 – volume: 4 start-page: 24 year: 2000 ident: 10.1016/j.addr.2022.114482_b1045 article-title: Herceptin: increasing survival in metastatic breast cancer publication-title: Eur. J. Oncol. Nurs. doi: 10.1054/ejon.2000.0070 – volume: 32 start-page: 2051 year: 2015 ident: 10.1016/j.addr.2022.114482_b0340 article-title: Dependence of PEI and PAMAM Gene Delivery on Clathrin- and Caveolin-Dependent Trafficking Pathways publication-title: Pharm. Res. doi: 10.1007/s11095-014-1598-6 – volume: 136 start-page: 4464 year: 2014 ident: 10.1016/j.addr.2022.114482_b1305 article-title: Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin publication-title: J. Am. Chem. Soc. doi: 10.1021/ja4124412 – volume: 13 year: 2021 ident: 10.1016/j.addr.2022.114482_b0175 article-title: Piceatannol-Loaded Bilosome-Stabilized Zein Protein Exhibits Enhanced Cytostatic and Apoptotic Activities in Lung Cancer Cells publication-title: Pharmaceutics doi: 10.3390/pharmaceutics13050638 – volume: 91 start-page: 10792 year: 2019 ident: 10.1016/j.addr.2022.114482_b1015 article-title: Aptamer-Functionalized and Gold Nanoparticle Array-Decorated Magnetic Graphene Nanosheets Enable Multiplexed and Sensitive Electrochemical Detection of Rare Circulating Tumor Cells in Whole Blood publication-title: Anal. Chem. doi: 10.1021/acs.analchem.9b02403 – volume: 18 start-page: 649 year: 2017 ident: 10.1016/j.addr.2022.114482_b0350 article-title: Stimuli-Responsive Polymersomes for Biomedical Applications publication-title: Biomacromolecules doi: 10.1021/acs.biomac.6b01704 – volume: 23 start-page: 7794 year: 2005 ident: 10.1016/j.addr.2022.114482_b0450 article-title: Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.04.937 – volume: 7 start-page: 193 year: 2020 ident: 10.1016/j.addr.2022.114482_b0095 article-title: Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2020.00193 – volume: 9 start-page: 8278 year: 2019 ident: 10.1016/j.addr.2022.114482_b0855 article-title: Surface modification of gold nanoparticles with neuron-targeted exosome for enhanced blood-brain barrier penetration publication-title: Sci. Rep. doi: 10.1038/s41598-019-44569-6 – volume: 383 start-page: 897 year: 2020 ident: 10.1016/j.addr.2022.114482_b0015 article-title: Progress in Cancer Research, Prevention, and Care publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp2007839 – volume: 32 start-page: 243 year: 2021 ident: 10.1016/j.addr.2022.114482_b0315 article-title: An overview of polymeric nanomicelles in clinical trials and on the market publication-title: Chin. Chem. Lett. doi: 10.1016/j.cclet.2020.11.029 – ident: 10.1016/j.addr.2022.114482_b1465 doi: 10.1126/sciadv.abk3150 – volume: 103 start-page: 213 year: 2020 ident: 10.1016/j.addr.2022.114482_b0240 article-title: siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery publication-title: Acta Biomater. doi: 10.1016/j.actbio.2019.12.005 – volume: 45 start-page: 1381 year: 2004 ident: 10.1016/j.addr.2022.114482_b0730 article-title: PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog publication-title: J. Nucl. Med. – volume: 22 start-page: 3574 year: 2021 ident: 10.1016/j.addr.2022.114482_b1385 article-title: Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders publication-title: Biomacromolecules doi: 10.1021/acs.biomac.1c00649 – volume: 15 start-page: 3843 year: 2020 ident: 10.1016/j.addr.2022.114482_b1545 article-title: Radiotherapy-Activated Hafnium Oxide Nanoparticles Produce Abscopal Effect in a Mouse Colorectal Cancer Model publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S250490 – volume: 573 year: 2020 ident: 10.1016/j.addr.2022.114482_b0345 article-title: Dendrimers in the context of nanomedicine publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2019.118814 – volume: 43 start-page: 1050 year: 2014 ident: 10.1016/j.addr.2022.114482_b0705 article-title: Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice publication-title: Pancreas doi: 10.1097/MPA.0000000000000194 – volume: 5 start-page: 11760 year: 2015 ident: 10.1016/j.addr.2022.114482_b1265 article-title: Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression publication-title: Sci. Rep. doi: 10.1038/srep11760 – volume: 89 start-page: 1 year: 2015 ident: 10.1016/j.addr.2022.114482_b0765 article-title: Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis publication-title: Ann. Surg. Treat Res. doi: 10.4174/astr.2015.89.1.1 – volume: 12 start-page: 3369 year: 2012 ident: 10.1016/j.addr.2022.114482_b0870 article-title: Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation publication-title: Nano Lett. doi: 10.1021/nl204175t – volume: 28 start-page: 471 year: 2017 ident: 10.1016/j.addr.2022.114482_b0755 article-title: Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization publication-title: Bioconjug. Chem. doi: 10.1021/acs.bioconjchem.6b00611 – volume: 290 start-page: 1 year: 2018 ident: 10.1016/j.addr.2022.114482_b1500 article-title: Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo publication-title: J. Control. Release doi: 10.1016/j.jconrel.2018.09.031 – volume: 11 year: 2021 ident: 10.1016/j.addr.2022.114482_b0925 article-title: FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients publication-title: Front. Oncol. – volume: 96 year: 2017 ident: 10.1016/j.addr.2022.114482_b0780 article-title: High VEGFR1/2 expression levels are predictors of poor survival in patients with cervical cancer publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000005772 – volume: 21 start-page: 1327 year: 2020 ident: 10.1016/j.addr.2022.114482_b0355 article-title: Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications publication-title: Biomacromolecules doi: 10.1021/acs.biomac.9b01754 – volume: 15 start-page: 213 year: 2014 ident: 10.1016/j.addr.2022.114482_b0430 article-title: Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy publication-title: AAPS PharmSciTech doi: 10.1208/s12249-013-0041-3 – volume: 112 start-page: 809 year: 2015 ident: 10.1016/j.addr.2022.114482_b1000 article-title: Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase publication-title: Br. J. Cancer doi: 10.1038/bjc.2015.8 – volume: 42 start-page: 419 year: 2003 ident: 10.1016/j.addr.2022.114482_b0905 article-title: Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies publication-title: Clin. Pharmacokinet. doi: 10.2165/00003088-200342050-00002 – volume: 128 year: 2020 ident: 10.1016/j.addr.2022.114482_b0650 article-title: Design of integrin alphavbeta3 targeting self-assembled protein nanoparticles with RGD peptide publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.110236 – volume: 4 start-page: 1129 year: 2012 ident: 10.1016/j.addr.2022.114482_b1490 article-title: Cancer-associated fibroblasts as targets for immunotherapy publication-title: Immunotherapy doi: 10.2217/imt.12.112 – volume: 9 start-page: 1738813 year: 2020 ident: 10.1016/j.addr.2022.114482_b0885 article-title: Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses publication-title: Oncoimmunology doi: 10.1080/2162402X.2020.1738813 – volume: 50 start-page: 417 year: 2017 ident: 10.1016/j.addr.2022.114482_b0205 article-title: The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response publication-title: Acta Biomater. doi: 10.1016/j.actbio.2017.01.005 – volume: 381 start-page: 338 year: 2019 ident: 10.1016/j.addr.2022.114482_b0600 article-title: Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1817323 – volume: 59 start-page: 1180 year: 2014 ident: 10.1016/j.addr.2022.114482_b0715 article-title: Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-014-3201-8 – volume: 17 start-page: 595 year: 2020 ident: 10.1016/j.addr.2022.114482_b1435 article-title: Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire, Nature Reviews publication-title: Clinical Oncology – volume: 26 year: 2015 ident: 10.1016/j.addr.2022.114482_b1085 article-title: Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI publication-title: Nanotechnology doi: 10.1088/0957-4484/26/7/075101 – volume: 72 start-page: 128 year: 2015 ident: 10.1016/j.addr.2022.114482_b0700 article-title: Insights into bombesin receptors and ligands: Highlighting recent advances publication-title: Peptides doi: 10.1016/j.peptides.2015.04.026 – volume: 13 start-page: 2155 year: 2016 ident: 10.1016/j.addr.2022.114482_b0335 article-title: Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.5b00946 – volume: 14 start-page: 1106 year: 2014 ident: 10.1016/j.addr.2022.114482_b0850 article-title: Overcoming cancer multidrug resistance by codelivery of doxorubicin and verapamil with hydrogel nanoparticles publication-title: Macromol. Biosci. doi: 10.1002/mabi.201400035 – volume: 12 year: 2017 ident: 10.1016/j.addr.2022.114482_b1165 article-title: The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis publication-title: PLoS ONE – volume: 47 start-page: 7029 year: 2008 ident: 10.1016/j.addr.2022.114482_b0390 article-title: Functionalized nanocompartments (synthosomes) with a reduction-triggered release system publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200801076 – volume: 13 start-page: 72 year: 2018 ident: 10.1016/j.addr.2022.114482_b0840 article-title: Synthetically lethal nanoparticles for treatment of endometrial cancer publication-title: Nat. Nanotechnol. doi: 10.1038/s41565-017-0009-7 – volume: 9 start-page: 1323 year: 2014 ident: 10.1016/j.addr.2022.114482_b1025 article-title: Near-infrared quantum dots for HER2 localization and imaging of cancer cells publication-title: Int. J. Nanomed. – volume: 88 year: 2020 ident: 10.1016/j.addr.2022.114482_b0540 article-title: Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2020.102064 – volume: 3 start-page: 965 year: 2020 ident: 10.1016/j.addr.2022.114482_b0040 article-title: Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design Synthesis, In Vitro, and In Vivo Anticancer Evaluation publication-title: ACS Pharmacol. Transl. Sci. doi: 10.1021/acsptsci.0c00096 – volume: 122 start-page: 931 year: 2020 ident: 10.1016/j.addr.2022.114482_b1485 article-title: The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome publication-title: Br. J. Cancer doi: 10.1038/s41416-019-0705-1 – volume: 121 start-page: 938 year: 2007 ident: 10.1016/j.addr.2022.114482_b0615 article-title: Folate receptor overexpression is associated with poor outcome in breast cancer publication-title: Int. J. Cancer doi: 10.1002/ijc.22811 – volume: 38 start-page: 3464 year: 2020 ident: 10.1016/j.addr.2022.114482_b0265 article-title: Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms publication-title: Vaccine doi: 10.1016/j.vaccine.2020.02.086 – volume: 154–155 start-page: 64 year: 2020 ident: 10.1016/j.addr.2022.114482_b0180 article-title: Recent advances in siRNA delivery mediated by lipid-based nanoparticles publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2020.07.022 – volume: 71 start-page: 209 issue: 2021 year: 2021 ident: 10.1016/j.addr.2022.114482_b0005 article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 11 start-page: 20140459 year: 2014 ident: 10.1016/j.addr.2022.114482_b0155 article-title: Liposomes in tissue engineering and regenerative medicine publication-title: J. R. Soc. Interface doi: 10.1098/rsif.2014.0459 – volume: 9 start-page: 639 year: 2009 ident: 10.1016/j.addr.2022.114482_b0560 article-title: The role of fibroblast growth factors in tumor growth publication-title: Curr. Cancer Drug Targets doi: 10.2174/156800909789057006 – volume: 16 start-page: 15 year: 2012 ident: 10.1016/j.addr.2022.114482_b0505 article-title: Targeting the EGFR signaling pathway in cancer therapy publication-title: Expert Opin Ther Targets doi: 10.1517/14728222.2011.648617 – volume: 9 start-page: 75 year: 2002 ident: 10.1016/j.addr.2022.114482_b1040 article-title: The development and clinical use of trastuzumab (Herceptin) publication-title: Endocr. Relat. Cancer doi: 10.1677/erc.0.0090075 – year: 2022 ident: 10.1016/j.addr.2022.114482_b0860 article-title: Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model publication-title: Bioconjug. Chem. doi: 10.1021/acs.bioconjchem.1c00479 – volume: 17 start-page: 862 year: 2017 ident: 10.1016/j.addr.2022.114482_b1505 article-title: Protein Nanocage Mediated Fibroblast-Activation Protein Targeted Photoimmunotherapy To Enhance Cytotoxic T Cell Infiltration and Tumor Control publication-title: Nano Lett. doi: 10.1021/acs.nanolett.6b04150 – volume: 22 start-page: 32 year: 2019 ident: 10.1016/j.addr.2022.114482_b0220 article-title: Polymeric Particles as Cancer Vaccine Vectors publication-title: Am. Pharm. Rev. – volume: 44 start-page: 2963 year: 2015 ident: 10.1016/j.addr.2022.114482_b0915 article-title: Cancer biomarker detection: recent achievements and challenges publication-title: Chem. Soc. Rev. doi: 10.1039/C4CS00370E – volume: 332 start-page: 127 year: 2021 ident: 10.1016/j.addr.2022.114482_b0295 article-title: Polymeric micelles in cancer therapy: State of the art publication-title: J. Control. Release doi: 10.1016/j.jconrel.2021.02.016 – volume: 2013 year: 2013 ident: 10.1016/j.addr.2022.114482_b0720 article-title: F-18 labeled vasoactive intestinal peptide analogue in the PET imaging of colon carcinoma in nude mice publication-title: Biomed. Res. Int. doi: 10.1155/2013/420480 – volume: 7 start-page: 3827 year: 2017 ident: 10.1016/j.addr.2022.114482_b0805 article-title: The Effect of shape on Cellular Uptake of Gold Nanoparticles in the forms of Stars Rods, and Triangles publication-title: Sci. Rep. doi: 10.1038/s41598-017-04229-z – volume: 139 start-page: 2892 year: 2017 ident: 10.1016/j.addr.2022.114482_b0495 article-title: Selection of 2'-Fluoro-Modified Aptamers with Optimized Properties publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.6b13132 – volume: 16 start-page: 71 year: 2018 ident: 10.1016/j.addr.2022.114482_b0085 article-title: Nano based drug delivery systems: recent developments and future prospects publication-title: J. Nanobiotechnol. doi: 10.1186/s12951-018-0392-8 – volume: 9 year: 2017 ident: 10.1016/j.addr.2022.114482_b0320 article-title: Dendrimer-based nanocarriers: a versatile platform for drug delivery publication-title: WIREs Nanomed. Nanobiotechnol. doi: 10.1002/wnan.1409 – volume: 130 start-page: 73 year: 2018 ident: 10.1016/j.addr.2022.114482_b0405 article-title: Harnessing albumin as a carrier for cancer therapies publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2018.07.011 – volume: 107 start-page: 52 year: 2007 ident: 10.1016/j.addr.2022.114482_b0625 article-title: Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas publication-title: Gynecol. Oncol. doi: 10.1016/j.ygyno.2007.05.018 – year: 2018 ident: 10.1016/j.addr.2022.114482_b0190 article-title: Advances in Biomaterials for Drug Delivery publication-title: Adv. Mater. doi: 10.1002/adma.201705328 – volume: 10 start-page: 26777 year: 2020 ident: 10.1016/j.addr.2022.114482_b0195 article-title: A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems, RSC publication-title: Advances – volume: 1 start-page: 16014 year: 2016 ident: 10.1016/j.addr.2022.114482_b0800 article-title: Analysis of nanoparticle delivery to tumours publication-title: Nat. Rev. Mater. doi: 10.1038/natrevmats.2016.14 – volume: 102 start-page: 13 year: 2020 ident: 10.1016/j.addr.2022.114482_b0130 article-title: Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy publication-title: Acta Biomater. doi: 10.1016/j.actbio.2019.11.027 – volume: 120 start-page: 169 year: 2007 ident: 10.1016/j.addr.2022.114482_b1030 article-title: Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome publication-title: J. Control. Release doi: 10.1016/j.jconrel.2007.05.011 – volume: 12 start-page: 76 year: 2019 ident: 10.1016/j.addr.2022.114482_b1475 article-title: Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0760-3 – volume: 18 start-page: 1862 year: 2021 ident: 10.1016/j.addr.2022.114482_b0415 article-title: The Uniqueness of Albumin as a Carrier in Nanodrug Delivery publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.1c00046 – volume: 15 start-page: 541 year: 2014 ident: 10.1016/j.addr.2022.114482_b1340 article-title: Non-viral vectors for gene-based therapy publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3763 – volume: 17 start-page: 1355 year: 2018 ident: 10.1016/j.addr.2022.114482_b0045 article-title: Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-17-1299 – volume: 82 start-page: 103 year: 2020 ident: 10.1016/j.addr.2022.114482_b0330 article-title: The Acidic Tumor Microenvironment as a Driver of Cancer publication-title: Annu. Rev. Physiol. doi: 10.1146/annurev-physiol-021119-034627 – volume: 12 year: 2020 ident: 10.1016/j.addr.2022.114482_b0460 article-title: Timeline of Translational Formulation Technologies for Cancer Therapy: Successes, Failures, and Lessons Learned Therefrom publication-title: Pharmaceutics doi: 10.3390/pharmaceutics12111028 – volume: 8 start-page: 727 year: 2020 ident: 10.1016/j.addr.2022.114482_b0380 article-title: Light-responsive polymersomes with a charge-switch for targeted drug delivery publication-title: J. Mater. Chem. B doi: 10.1039/C9TB02411E – volume: 15 start-page: 73 year: 2017 ident: 10.1016/j.addr.2022.114482_b0910 article-title: Protein Array-based Approaches for Biomarker Discovery in Cancer publication-title: Genom. Proteom. Bioinform. doi: 10.1016/j.gpb.2017.03.001 – volume: 3 year: 2013 ident: 10.1016/j.addr.2022.114482_b0740 article-title: Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells publication-title: Drug Deliv Transl Res doi: 10.1007/s13346-013-0167-6 – volume: 8 start-page: 5040 year: 2016 ident: 10.1016/j.addr.2022.114482_b0810 article-title: Surface Modification of Gd Nanoparticles with pH-Responsive Block Copolymers for Use As Smart MRI Contrast Agents publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.5b12463 – volume: 6 start-page: 27559 year: 2016 ident: 10.1016/j.addr.2022.114482_b1200 article-title: Core-shell nanocarriers with high paclitaxel loading for passive and active targeting publication-title: Sci. Rep. doi: 10.1038/srep27559 – volume: 34 start-page: 3626 year: 2013 ident: 10.1016/j.addr.2022.114482_b0835 article-title: The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.01.078 – volume: 14 start-page: 9693 year: 2019 ident: 10.1016/j.addr.2022.114482_b0530 article-title: Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S226628 – volume: 13 start-page: 763 year: 2018 ident: 10.1016/j.addr.2022.114482_b1215 article-title: Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S149887 – volume: 44 start-page: 131 year: 2018 ident: 10.1016/j.addr.2022.114482_b1410 article-title: Possible strategies to cross the blood-brain barrier publication-title: Ital J Pediatr doi: 10.1186/s13052-018-0563-0 – volume: 23 start-page: 248 year: 2022 ident: 10.1016/j.addr.2022.114482_b0595 article-title: Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(21)00660-4 – volume: 8 start-page: 1809 year: 2008 ident: 10.1016/j.addr.2022.114482_b0960 article-title: Quantum dot-based protein micro- and nanoarrays for detection of prostate cancer biomarkers publication-title: Proteomics doi: 10.1002/pmic.200701072 – year: 2021 ident: 10.1016/j.addr.2022.114482_b0280 article-title: Nanoparticles in the clinic: An update post COVID-19 vaccines publication-title: Bioeng. Transl. Med. doi: 10.1002/btm2.10246 – volume: 12 year: 2020 ident: 10.1016/j.addr.2022.114482_b0455 article-title: Protein-Based Nanoparticles as Drug Delivery Systems publication-title: Pharmaceutics doi: 10.3390/pharmaceutics12070604 – volume: 18 start-page: 457 year: 2010 ident: 10.1016/j.addr.2022.114482_b0735 article-title: VPAC receptor mediated tumor cell targeting by protamine based nanoparticles publication-title: J. Drug Target. doi: 10.3109/10611860903508796 – volume: 5 start-page: 405 year: 2020 ident: 10.1016/j.addr.2022.114482_b0250 article-title: Enabling technologies in polymer synthesis: accessing a new design space for advanced polymer materials publication-title: React. Chem. Eng. doi: 10.1039/C9RE00474B – volume: 20 start-page: 3989 year: 2019 ident: 10.1016/j.addr.2022.114482_b0370 article-title: Temperature-Responsive Polymersomes of Poly(3-methyl-N-vinylcaprolactam)-block-poly(N-vinylpyrrolidone) To Decrease Doxorubicin-Induced Cardiotoxicity publication-title: Biomacromolecules doi: 10.1021/acs.biomac.9b01026 – volume: 12 start-page: 3119 year: 2015 ident: 10.1016/j.addr.2022.114482_b1150 article-title: Dual-Modality Noninvasive Mapping of Sentinel Lymph Node by Photoacoustic and Near-Infrared Fluorescent Imaging Using Dye-Loaded Mesoporous Silica Nanoparticles publication-title: Mol. Pharm. doi: 10.1021/mp500698b – volume: 152 start-page: 47 year: 2018 ident: 10.1016/j.addr.2022.114482_b1275 article-title: Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.10.035 – volume: 118 start-page: 1 year: 2013 ident: 10.1016/j.addr.2022.114482_b0775 article-title: Bioengineering strategies for designing targeted cancer therapies publication-title: Adv. Cancer Res. doi: 10.1016/B978-0-12-407173-5.00002-9 – volume: 12 start-page: 1030 year: 2022 ident: 10.1016/j.addr.2022.114482_b0260 article-title: Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies publication-title: Theranostics doi: 10.7150/thno.64805 – volume: 21 start-page: 534 year: 2020 ident: 10.1016/j.addr.2022.114482_b0270 article-title: Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral Antigens publication-title: Biomacromolecules doi: 10.1021/acs.biomac.9b01257 – volume: 192 start-page: 209 year: 2014 ident: 10.1016/j.addr.2022.114482_b1450 article-title: Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study publication-title: J. Control. Release doi: 10.1016/j.jconrel.2014.07.040 – volume: 4 start-page: 143 year: 2013 ident: 10.1016/j.addr.2022.114482_b0160 article-title: The use of lipid-based nanocarriers for targeted pain therapies publication-title: Front. Pharmacol. doi: 10.3389/fphar.2013.00143 – volume: 12 start-page: 177 year: 2018 ident: 10.1016/j.addr.2022.114482_b0325 article-title: PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy publication-title: Appl. Mater. Today doi: 10.1016/j.apmt.2018.05.002 – volume: 92 start-page: 183 year: 2016 ident: 10.1016/j.addr.2022.114482_b1180 article-title: Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2016.07.007 – volume: 6 start-page: 3695 year: 2012 ident: 10.1016/j.addr.2022.114482_b1135 article-title: Ag2S quantum dot: a bright and biocompatible fluorescent nanoprobe in the second near-infrared window publication-title: ACS Nano doi: 10.1021/nn301218z – volume: 6 start-page: 10095 year: 2014 ident: 10.1016/j.addr.2022.114482_b1535 article-title: Enhanced radiation therapy with internalized polyelectrolyte modified nanoparticles publication-title: Nanoscale doi: 10.1039/C4NR01564A – volume: 2019 start-page: 1579 year: 1861 ident: 10.1016/j.addr.2022.114482_b1420 article-title: Lidocaine turns the surface charge of biological membranes more positive and changes the permeability of blood-brain barrier culture models publication-title: Biochim. Biophys. Acta, Biomembr. – volume: 99 start-page: 28 year: 2016 ident: 10.1016/j.addr.2022.114482_b0500 article-title: PEGylation as a strategy for improving nanoparticle-based drug and gene delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2015.09.012 – volume: 81 start-page: 7009 year: 2009 ident: 10.1016/j.addr.2022.114482_b1050 article-title: Using aptamer-conjugated fluorescence resonance energy transfer nanoparticles for multiplexed cancer cell monitoring publication-title: Anal. Chem. doi: 10.1021/ac9011073 – ident: 10.1016/j.addr.2022.114482_b0030 doi: 10.1177/0046958019880696 – volume: 34 start-page: 1953 year: 2015 ident: 10.1016/j.addr.2022.114482_b1210 article-title: Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes publication-title: Oncol. Rep. doi: 10.3892/or.2015.4136 – volume: 338 start-page: 284 year: 2005 ident: 10.1016/j.addr.2022.114482_b0620 article-title: Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay publication-title: Anal. Biochem. doi: 10.1016/j.ab.2004.12.026 – volume: 130 start-page: 16778 year: 2008 ident: 10.1016/j.addr.2022.114482_b1460 article-title: Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery publication-title: J. Am. Chem. Soc. doi: 10.1021/ja805570f – volume: 9 start-page: 202 year: 2018 ident: 10.1016/j.addr.2022.114482_b0895 article-title: Poly(Ethylene Glycol)-Polylactide Micelles for Cancer Therapy publication-title: Front. Pharmacol. doi: 10.3389/fphar.2018.00202 – volume: 24 start-page: 2442 year: 2014 ident: 10.1016/j.addr.2022.114482_b0300 article-title: Dendron-Based Micelles for Topical Delivery of Endoxifen: A Potential Chemo-Preventive Medicine for Breast Cancer publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201303253 – volume: 8 start-page: 2000 year: 2014 ident: 10.1016/j.addr.2022.114482_b0760 article-title: A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy publication-title: Oncol. Lett. doi: 10.3892/ol.2014.2449 – volume: 12 start-page: 7291 year: 2017 ident: 10.1016/j.addr.2022.114482_b1175 article-title: Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S146315 – volume: 6 start-page: 7607 year: 2012 ident: 10.1016/j.addr.2022.114482_b0980 article-title: Single-step nanoplasmonic VEGF165 aptasensor for early cancer diagnosis publication-title: ACS Nano doi: 10.1021/nn203833d – volume: 20 start-page: 9042 year: 2010 ident: 10.1016/j.addr.2022.114482_b1120 article-title: 99mTc-hematoporphyrin linked albumin nanoparticles for lung cancer targeted photodynamic therapy and imaging publication-title: J. Mater. Chem. doi: 10.1039/c0jm01544j – volume: 3 start-page: 721 year: 2015 ident: 10.1016/j.addr.2022.114482_b1090 article-title: Facile synthesis of RGD peptide-modified iron oxide nanoparticles with ultrahigh relaxivity for targeted MR imaging of tumors publication-title: Biomater. Sci. doi: 10.1039/C5BM00037H – volume: 419 start-page: 33 year: 2016 ident: 10.1016/j.addr.2022.114482_b1080 article-title: The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging publication-title: Carbohydr. Res. doi: 10.1016/j.carres.2015.11.003 – volume: 216 start-page: 347 year: 2008 ident: 10.1016/j.addr.2022.114482_b1145 article-title: Tumor lymphangiogenesis and melanoma metastasis publication-title: J. Cell. Physiol. doi: 10.1002/jcp.21494 – volume: 11 start-page: 46585 year: 2019 ident: 10.1016/j.addr.2022.114482_b1360 article-title: Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/acsami.9b17749 – volume: 22 year: 2021 ident: 10.1016/j.addr.2022.114482_b1400 article-title: Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms222313160 – volume: 29 start-page: 1603239 year: 2017 ident: 10.1016/j.addr.2022.114482_b0110 article-title: Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy publication-title: Adv. Mater. doi: 10.1002/adma.201603239 – volume: 9 start-page: 3480 year: 2019 ident: 10.1016/j.addr.2022.114482_b0585 article-title: Nuclear FGFR2 negatively regulates hypoxia-induced cell invasion in prostate cancer by interacting with HIF-1 and HIF-2 publication-title: Sci. Rep. doi: 10.1038/s41598-019-39843-6 – volume: 344 start-page: 1373 year: 2001 ident: 10.1016/j.addr.2022.114482_b0955 article-title: Prostate-Specific–Antigen Testing for Early Diagnosis of Prostate Cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200105033441806 – volume: 178 start-page: 81 year: 2012 ident: 10.1016/j.addr.2022.114482_b0970 article-title: Electrochemical immunosensor for prostate-specific antigen using a glassy carbon electrode modified with a nanocomposite containing gold nanoparticles supported with starch-functionalized multi-walled carbon nanotubes publication-title: Microchim. Acta doi: 10.1007/s00604-012-0816-3 – volume: 12 start-page: 5069 year: 2017 ident: 10.1016/j.addr.2022.114482_b1530 article-title: Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S137833 – volume: 19 start-page: 341 year: 2019 ident: 10.1016/j.addr.2022.114482_b0995 article-title: Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model publication-title: Cancer Cell Int doi: 10.1186/s12935-019-1067-8 – volume: 26 start-page: 87 year: 2014 ident: 10.1016/j.addr.2022.114482_b1130 article-title: Changes in cell and tissue organization in cancer of the breast and colon publication-title: Curr. Opin. Cell Biol. doi: 10.1016/j.ceb.2013.11.003 – volume: 9 start-page: 8012 year: 2015 ident: 10.1016/j.addr.2022.114482_b1290 article-title: Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis publication-title: ACS Nano doi: 10.1021/acsnano.5b01552 – volume: 15 start-page: 81 year: 2020 ident: 10.1016/j.addr.2022.114482_b1060 article-title: Multi-mode biodegradable tumour-microenvironment sensitive nanoparticles for targeted breast cancer imaging publication-title: Nanoscale Res. Lett. doi: 10.1186/s11671-020-03309-w – volume: 12 start-page: 855 year: 2019 ident: 10.1016/j.addr.2022.114482_b1355 article-title: Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer publication-title: Nano Res. doi: 10.1007/s12274-019-2308-9 – volume: 24 year: 2020 ident: 10.1016/j.addr.2022.114482_b1325 article-title: Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer publication-title: Nanomedicine – volume: 17 start-page: 1723 year: 2019 ident: 10.1016/j.addr.2022.114482_b0660 article-title: Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells publication-title: Oncol Lett – volume: 34 start-page: 3617 year: 2015 ident: 10.1016/j.addr.2022.114482_b0035 article-title: Mechanism-based cancer therapy: resistance to therapy, therapy for resistance publication-title: Oncogene doi: 10.1038/onc.2014.314 – volume: 52 start-page: 978 year: 2014 ident: 10.1016/j.addr.2022.114482_b1250 article-title: Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy publication-title: Pharm. Biol. doi: 10.3109/13880209.2013.874533 – volume: 6 start-page: 2039 year: 2016 ident: 10.1016/j.addr.2022.114482_b0865 article-title: Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery publication-title: Theranostics doi: 10.7150/thno.17098 – volume: 46 start-page: 13 year: 2015 ident: 10.1016/j.addr.2022.114482_b1350 article-title: Co-delivery of HIF1alpha siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.12.028 – volume: 14 start-page: 823 year: 2020 ident: 10.1016/j.addr.2022.114482_b1205 article-title: Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles publication-title: Drug Des. Devel. Ther. doi: 10.2147/DDDT.S235098 – volume: 230 start-page: 259 year: 2015 ident: 10.1016/j.addr.2022.114482_b1335 article-title: Gene Therapies for Cancer: Strategies, Challenges and Successes publication-title: J. Cell. Physiol. doi: 10.1002/jcp.24791 – volume: 10 start-page: 1606 year: 2020 ident: 10.1016/j.addr.2022.114482_b0255 article-title: Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells publication-title: Sci. Rep. doi: 10.1038/s41598-020-58527-0 – volume: 15 start-page: 353 year: 2018 ident: 10.1016/j.addr.2022.114482_b0930 article-title: Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers publication-title: Expert Rev. Proteom. doi: 10.1080/14789450.2018.1450631 – volume: 129 start-page: 15477 year: 2007 ident: 10.1016/j.addr.2022.114482_b1110 article-title: Nano-flares: probes for transfection and mRNA detection in living cells publication-title: J. Am. Chem. Soc. doi: 10.1021/ja0776529 – volume: 140 start-page: 162 year: 2017 ident: 10.1016/j.addr.2022.114482_b0410 article-title: Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.06.021 – volume: 2013 year: 2013 ident: 10.1016/j.addr.2022.114482_b0510 article-title: The role of epidermal growth factor receptor in cancer metastasis and microenvironment publication-title: Biomed Res. Int. doi: 10.1155/2013/546318 – volume: 9 start-page: 1362 year: 2013 ident: 10.1016/j.addr.2022.114482_b0100 article-title: Surface functionalized gold nanoparticles for drug delivery publication-title: J. Biomed. Nanotechnol. doi: 10.1166/jbn.2013.1536 – volume: 49 start-page: 112 year: 2008 ident: 10.1016/j.addr.2022.114482_b0725 article-title: PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer publication-title: J. Nucl. Med. doi: 10.2967/jnumed.107.043703 – volume: 47 start-page: 8572 year: 2018 ident: 10.1016/j.addr.2022.114482_b0400 article-title: Liposomes and polymersomes: a comparative review towards cell mimicking publication-title: Chem. Soc. Rev. doi: 10.1039/C8CS00162F – volume: 11 year: 2021 ident: 10.1016/j.addr.2022.114482_b1300 article-title: Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting publication-title: Nanomaterials (Basel) doi: 10.3390/nano11010177 – volume: 101 start-page: 570 year: 2007 ident: 10.1016/j.addr.2022.114482_b0645 article-title: Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.107.155655 – volume: 184 start-page: 3049 year: 2017 ident: 10.1016/j.addr.2022.114482_b0945 article-title: Nanomaterial-based biosensors for detection of prostate specific antigen publication-title: Mikrochim. Acta doi: 10.1007/s00604-017-2410-1 – volume: 411 start-page: 985 year: 2019 ident: 10.1016/j.addr.2022.114482_b1020 article-title: A novel magnetic fluorescent biosensor based on graphene quantum dots for rapid, efficient, and sensitive separation and detection of circulating tumor cells publication-title: Anal. Bioanal. Chem. doi: 10.1007/s00216-018-1501-0 – volume: 31 start-page: 4499 year: 2012 ident: 10.1016/j.addr.2022.114482_b1140 article-title: Interaction of tumor cells and lymphatic vessels in cancer progression publication-title: Oncogene doi: 10.1038/onc.2011.602 |
| SSID | ssj0012760 |
| Score | 2.5446866 |
| SecondaryResourceType | review_article |
| Snippet | [Display omitted]
•Progress of preclinical and clinical research into engineered nanomedicine is helping to bring new effective diagnostic and therapeutic... Over the past two decades, multidisciplinary investigations into the development of nanoparticles for medical applications have continually increased. However,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 114482 |
| SubjectTerms | Cancer imaging and diagnosis Cancer therapy Drug delivery and targeting Drug Delivery Systems Engineered nanoparticles Humans Nanomedicine Nanomedicine - methods Nanoparticles - therapeutic use Neoplasms - diagnosis Neoplasms - drug therapy Surface chemistry Surface engineering Surface-functionalization Surface-modification Tissue Distribution Tumor-targeted nanoparticles |
| Title | Engineering nanosystems to overcome barriers to cancer diagnosis and treatment |
| URI | https://dx.doi.org/10.1016/j.addr.2022.114482 https://www.ncbi.nlm.nih.gov/pubmed/35944587 https://www.proquest.com/docview/2700642637 |
| Volume | 189 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB5EEbyIrq_1RQTxonXbPJrucRFlVVwEFfYW0jSFFeku-zjsxd9upmlXPbgHb21I2pCZzGTIN98AnIcxjXSmw6Adut3EcyOCNDXuSYskymPn9BNMTn7qxd03_tAX_RW4qXNhEFZZ2X5v00trXbW0qtVsjQaD1gvyiLjopE8RXyUp0m5zLlHLrz8XMI-IyjJTGDsH2LtKnPEYL7e5kROUUqTM5Qn9yzn9dfgsndDdFmxWp0fS8RPchhVbNGDd15OcN-Di2RNRz6_I63de1eSKXJDnb4rq-Q70ftAQkkIXQ0_oPCHTIUFMp1sNS1I9xnJ2ZaNB5RiTzAPzBhOii4wsQOq78HZ3-3rTDarKCoFhIp4G0h1rUsNyJwyZJywPTURpxiRPEfYkBWcsd4GczTDNVhsX9dC20TY0Lr6imku2B6vFsLAHQMLMGQ0T8ihNDHff0rHgWjIbSpMngtsmRPWSKlPRjmP1iw9V48veFYpBoRiUF0MTLhdjRp50Y2lvUUtK_VId5bzC0nFntViV21N4UaILO5xNFF7Gx8hkL5uw7-W9mAcTbc5FIg__-dcj2MA3jwc8htXpeGZP3Llmmp6WinsKa537x27vC-8c9QE |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RKlQuqKU8lkfrShUXCJv4EWePFSratrBCYpH2ZjmOIy1CWbS7HPbCb2cmTpZygAO3yLETy-OZ8cjffAPwM055YgsbR70YtUmWTkV57vDJqiwpU3T6GSUnXw7S_o38O1KjFThrc2EIVtnY_mDTa2vdtHSb1ezej8fda-IRwehkxAlfpXn6AT5KVF8qY3D6uMR5JFzXqcLUO6LuTeZMAHmhdhMpKOfEmSsz_pp3eu30WXuh88-w0Rwf2a8wwy-w4qtNWAsFJRebcHQVmKgXJ2z4nFg1O2FH7OqZo3rxFQb_8RCyylaTwOg8Y_MJI1AnLodnuZ1SPbu60dHumLIiIPPGM2argi1R6ltwc_57eNaPmtIKkRMqnUcazzW5EyVKQ5eZKGOXcF4ILXPCPWklhSgxkvMF5dlah2EP7znrY4cBFrdSi21YrSaV3wUWF2g1XCyTPHMSv2VTJa0WPtauzJT0HUjaJTWu4R2n8hd3pgWY3RoSgyExmCCGDhwvx9wH1o03e6tWUubF3jHoFt4c96MVq0GlopsSW_nJw8zQbXxKVPa6AztB3st5CNWTUmV6751__Q6f-sPLC3PxZ_BvH9bpTQAHHsDqfPrgD_GQM8-_1Zv4CYjm9o8 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+nanosystems+to+overcome+barriers+to+cancer+diagnosis+and+treatment&rft.jtitle=Advanced+drug+delivery+reviews&rft.au=Alhaj-Suliman%2C+Suhaila+O.&rft.au=Wafa%2C+Emad+I.&rft.au=Salem%2C+Aliasger+K.&rft.date=2022-10-01&rft.issn=0169-409X&rft.volume=189&rft.spage=114482&rft_id=info:doi/10.1016%2Fj.addr.2022.114482&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_addr_2022_114482 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0169-409X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0169-409X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0169-409X&client=summon |